Project
SARS-CoV-2 Analysis Results (GEO series: GSE147507)
Navigation
Downloads
Results for RUNX1_RUNX2
Z-value: 1.55
Motif logo
Transcription factors associated with RUNX1_RUNX2
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
RUNX1
|
ENSG00000159216.14 | RUNX family transcription factor 1 |
|
RUNX2
|
ENSG00000124813.16 | RUNX family transcription factor 2 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| RUNX1 | hg19_v2_chr21_-_36421535_36421610 | -0.96 | 2.2e-11 | Click! |
| RUNX2 | hg19_v2_chr6_+_45296048_45296106 | -0.90 | 6.4e-08 | Click! |
Activity profile of RUNX1_RUNX2 motif
Sorted Z-values of RUNX1_RUNX2 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr17_+_32582293 | 9.91 |
ENST00000580907.1
ENST00000225831.4 |
CCL2
|
chemokine (C-C motif) ligand 2 |
| chr11_-_117699413 | 7.23 |
ENST00000528014.1
|
FXYD2
|
FXYD domain containing ion transport regulator 2 |
| chr4_+_88896819 | 7.07 |
ENST00000237623.7
ENST00000395080.3 ENST00000508233.1 ENST00000360804.4 |
SPP1
|
secreted phosphoprotein 1 |
| chr17_+_73780852 | 5.83 |
ENST00000589666.1
|
UNK
|
unkempt family zinc finger |
| chr2_+_169659121 | 5.59 |
ENST00000397206.2
ENST00000397209.2 ENST00000421711.2 |
NOSTRIN
|
nitric oxide synthase trafficking |
| chr1_-_153517473 | 5.42 |
ENST00000368715.1
|
S100A4
|
S100 calcium binding protein A4 |
| chr19_-_36233332 | 5.15 |
ENST00000592537.1
ENST00000246532.1 ENST00000344990.3 ENST00000588992.1 |
IGFLR1
|
IGF-like family receptor 1 |
| chr12_-_8693469 | 5.10 |
ENST00000545274.1
ENST00000446457.2 |
CLEC4E
|
C-type lectin domain family 4, member E |
| chr2_+_169658928 | 4.85 |
ENST00000317647.7
ENST00000445023.2 |
NOSTRIN
|
nitric oxide synthase trafficking |
| chr22_+_22988816 | 4.64 |
ENST00000480559.1
ENST00000448514.1 |
GGTLC2
|
gamma-glutamyltransferase light chain 2 |
| chr17_-_15165854 | 4.54 |
ENST00000395936.1
ENST00000395938.2 |
PMP22
|
peripheral myelin protein 22 |
| chr12_+_47610315 | 4.49 |
ENST00000548348.1
ENST00000549500.1 |
PCED1B
|
PC-esterase domain containing 1B |
| chr19_+_54495542 | 4.49 |
ENST00000252729.2
ENST00000352529.1 |
CACNG6
|
calcium channel, voltage-dependent, gamma subunit 6 |
| chr12_-_8693539 | 4.22 |
ENST00000299663.3
|
CLEC4E
|
C-type lectin domain family 4, member E |
| chr11_-_117698787 | 4.10 |
ENST00000260287.2
|
FXYD2
|
FXYD domain containing ion transport regulator 2 |
| chr12_-_58027138 | 3.87 |
ENST00000341156.4
|
B4GALNT1
|
beta-1,4-N-acetyl-galactosaminyl transferase 1 |
| chr20_+_43343886 | 3.85 |
ENST00000190983.4
|
WISP2
|
WNT1 inducible signaling pathway protein 2 |
| chr16_+_57844549 | 3.82 |
ENST00000564282.1
|
CTD-2600O9.1
|
uncharacterized protein LOC388282 |
| chr5_+_175298487 | 3.72 |
ENST00000393745.3
|
CPLX2
|
complexin 2 |
| chr22_+_21996549 | 3.71 |
ENST00000248958.4
|
SDF2L1
|
stromal cell-derived factor 2-like 1 |
| chr11_+_2923423 | 3.69 |
ENST00000312221.5
|
SLC22A18
|
solute carrier family 22, member 18 |
| chr8_-_19540266 | 3.66 |
ENST00000311540.4
|
CSGALNACT1
|
chondroitin sulfate N-acetylgalactosaminyltransferase 1 |
| chr8_+_35649365 | 3.63 |
ENST00000437887.1
|
AC012215.1
|
Uncharacterized protein |
| chr9_-_116840728 | 3.57 |
ENST00000265132.3
|
AMBP
|
alpha-1-microglobulin/bikunin precursor |
| chr8_-_19540086 | 3.52 |
ENST00000332246.6
|
CSGALNACT1
|
chondroitin sulfate N-acetylgalactosaminyltransferase 1 |
| chr7_+_76054224 | 3.51 |
ENST00000394857.3
|
ZP3
|
zona pellucida glycoprotein 3 (sperm receptor) |
| chr11_+_2923499 | 3.46 |
ENST00000449793.2
|
SLC22A18
|
solute carrier family 22, member 18 |
| chr2_+_37571717 | 3.46 |
ENST00000338415.3
ENST00000404976.1 |
QPCT
|
glutaminyl-peptide cyclotransferase |
| chr20_+_43343476 | 3.38 |
ENST00000372868.2
|
WISP2
|
WNT1 inducible signaling pathway protein 2 |
| chr12_-_58027002 | 3.25 |
ENST00000449184.3
|
B4GALNT1
|
beta-1,4-N-acetyl-galactosaminyl transferase 1 |
| chr11_-_102401469 | 3.25 |
ENST00000260227.4
|
MMP7
|
matrix metallopeptidase 7 (matrilysin, uterine) |
| chr11_-_117698765 | 3.13 |
ENST00000532119.1
|
FXYD2
|
FXYD domain containing ion transport regulator 2 |
| chr22_+_25003626 | 3.10 |
ENST00000451366.1
ENST00000406383.2 ENST00000428855.1 |
GGT1
|
gamma-glutamyltransferase 1 |
| chr19_+_859425 | 3.05 |
ENST00000327726.6
|
CFD
|
complement factor D (adipsin) |
| chr2_+_37571845 | 3.04 |
ENST00000537448.1
|
QPCT
|
glutaminyl-peptide cyclotransferase |
| chr20_+_43343517 | 3.04 |
ENST00000372865.4
|
WISP2
|
WNT1 inducible signaling pathway protein 2 |
| chrY_+_2709906 | 3.03 |
ENST00000430575.1
|
RPS4Y1
|
ribosomal protein S4, Y-linked 1 |
| chr2_-_27531313 | 2.97 |
ENST00000296099.2
|
UCN
|
urocortin |
| chr11_+_118958689 | 2.82 |
ENST00000535253.1
ENST00000392841.1 |
HMBS
|
hydroxymethylbilane synthase |
| chr20_-_62199427 | 2.81 |
ENST00000427522.2
|
HELZ2
|
helicase with zinc finger 2, transcriptional coactivator |
| chr5_-_108063949 | 2.79 |
ENST00000606054.1
|
LINC01023
|
long intergenic non-protein coding RNA 1023 |
| chr8_+_144640477 | 2.72 |
ENST00000262580.4
|
GSDMD
|
gasdermin D |
| chr2_+_8822113 | 2.68 |
ENST00000396290.1
ENST00000331129.3 |
ID2
|
inhibitor of DNA binding 2, dominant negative helix-loop-helix protein |
| chr19_+_859654 | 2.67 |
ENST00000592860.1
|
CFD
|
complement factor D (adipsin) |
| chr19_-_55895966 | 2.65 |
ENST00000444469.3
|
TMEM238
|
transmembrane protein 238 |
| chr11_-_64885111 | 2.62 |
ENST00000528598.1
ENST00000310597.4 |
ZNHIT2
|
zinc finger, HIT-type containing 2 |
| chr17_-_15165825 | 2.61 |
ENST00000426385.3
|
PMP22
|
peripheral myelin protein 22 |
| chr11_+_7626950 | 2.56 |
ENST00000530181.1
|
PPFIBP2
|
PTPRF interacting protein, binding protein 2 (liprin beta 2) |
| chr19_-_18391708 | 2.47 |
ENST00000600972.1
|
JUND
|
jun D proto-oncogene |
| chr14_-_23822080 | 2.43 |
ENST00000397267.1
ENST00000354772.3 |
SLC22A17
|
solute carrier family 22, member 17 |
| chr5_+_175298573 | 2.39 |
ENST00000512824.1
|
CPLX2
|
complexin 2 |
| chr12_+_54384370 | 2.37 |
ENST00000504315.1
|
HOXC6
|
homeobox C6 |
| chr1_+_66796401 | 2.31 |
ENST00000528771.1
|
PDE4B
|
phosphodiesterase 4B, cAMP-specific |
| chr8_-_102803163 | 2.31 |
ENST00000523645.1
ENST00000520346.1 ENST00000220931.6 ENST00000522448.1 ENST00000522951.1 ENST00000522252.1 ENST00000519098.1 |
NCALD
|
neurocalcin delta |
| chr6_-_64029879 | 2.30 |
ENST00000370658.5
ENST00000485906.2 ENST00000370657.4 |
LGSN
|
lengsin, lens protein with glutamine synthetase domain |
| chr11_+_67777751 | 2.29 |
ENST00000316367.6
ENST00000007633.8 ENST00000342456.6 |
ALDH3B1
|
aldehyde dehydrogenase 3 family, member B1 |
| chr14_-_35183886 | 2.28 |
ENST00000298159.6
|
CFL2
|
cofilin 2 (muscle) |
| chr16_+_89979826 | 2.26 |
ENST00000555427.1
|
MC1R
|
melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor) |
| chr17_+_38599693 | 2.23 |
ENST00000542955.1
ENST00000269593.4 |
IGFBP4
|
insulin-like growth factor binding protein 4 |
| chr17_-_43025005 | 2.23 |
ENST00000587309.1
ENST00000593135.1 ENST00000339151.4 |
KIF18B
|
kinesin family member 18B |
| chr14_-_23285069 | 2.23 |
ENST00000554758.1
ENST00000397528.4 |
SLC7A7
|
solute carrier family 7 (amino acid transporter light chain, y+L system), member 7 |
| chrX_-_30327495 | 2.21 |
ENST00000453287.1
|
NR0B1
|
nuclear receptor subfamily 0, group B, member 1 |
| chr7_+_134832808 | 2.13 |
ENST00000275767.3
|
TMEM140
|
transmembrane protein 140 |
| chr8_+_144640499 | 2.12 |
ENST00000525721.1
ENST00000534018.1 |
GSDMD
|
gasdermin D |
| chr17_+_42634844 | 2.11 |
ENST00000315323.3
|
FZD2
|
frizzled family receptor 2 |
| chr15_-_72668805 | 2.09 |
ENST00000268097.5
|
HEXA
|
hexosaminidase A (alpha polypeptide) |
| chr16_-_57513657 | 2.09 |
ENST00000566936.1
ENST00000568617.1 ENST00000567276.1 ENST00000569548.1 ENST00000569250.1 ENST00000564378.1 |
DOK4
|
docking protein 4 |
| chr17_-_26695013 | 2.09 |
ENST00000555059.2
|
CTB-96E2.2
|
Homeobox protein SEBOX |
| chr6_-_31745085 | 2.09 |
ENST00000375686.3
ENST00000447450.1 |
VWA7
|
von Willebrand factor A domain containing 7 |
| chr15_-_72668185 | 2.08 |
ENST00000457859.2
ENST00000566304.1 ENST00000567159.1 ENST00000429918.2 |
HEXA
|
hexosaminidase A (alpha polypeptide) |
| chr22_+_25003606 | 2.06 |
ENST00000432867.1
|
GGT1
|
gamma-glutamyltransferase 1 |
| chr12_-_49463753 | 2.04 |
ENST00000301068.6
|
RHEBL1
|
Ras homolog enriched in brain like 1 |
| chr1_+_198608146 | 2.02 |
ENST00000367376.2
ENST00000352140.3 ENST00000594404.1 ENST00000598951.1 ENST00000530727.1 ENST00000442510.2 ENST00000367367.4 ENST00000348564.6 ENST00000367364.1 ENST00000413409.2 |
PTPRC
|
protein tyrosine phosphatase, receptor type, C |
| chr14_-_23822061 | 2.02 |
ENST00000397260.3
|
SLC22A17
|
solute carrier family 22, member 17 |
| chr16_+_29674540 | 2.02 |
ENST00000436527.1
ENST00000360121.3 ENST00000449759.1 |
SPN
QPRT
|
sialophorin quinolinate phosphoribosyltransferase |
| chr4_+_178230985 | 2.02 |
ENST00000264596.3
|
NEIL3
|
nei endonuclease VIII-like 3 (E. coli) |
| chr11_-_1606513 | 1.99 |
ENST00000382171.2
|
KRTAP5-1
|
keratin associated protein 5-1 |
| chr19_-_41256207 | 1.99 |
ENST00000598485.2
ENST00000470681.1 ENST00000339153.3 ENST00000598729.1 |
C19orf54
|
chromosome 19 open reading frame 54 |
| chr6_-_34524049 | 1.98 |
ENST00000374037.3
|
SPDEF
|
SAM pointed domain containing ETS transcription factor |
| chr10_+_104221137 | 1.96 |
ENST00000366277.2
ENST00000238936.4 ENST00000369931.3 |
TMEM180
|
transmembrane protein 180 |
| chr17_-_26694979 | 1.95 |
ENST00000438614.1
|
VTN
|
vitronectin |
| chr10_+_70847852 | 1.95 |
ENST00000242465.3
|
SRGN
|
serglycin |
| chr22_+_25003568 | 1.94 |
ENST00000447416.1
|
GGT1
|
gamma-glutamyltransferase 1 |
| chr6_-_30709980 | 1.94 |
ENST00000416018.1
ENST00000445853.1 ENST00000413165.1 ENST00000418160.1 |
FLOT1
|
flotillin 1 |
| chr12_+_113344811 | 1.94 |
ENST00000551241.1
ENST00000553185.1 ENST00000550689.1 |
OAS1
|
2'-5'-oligoadenylate synthetase 1, 40/46kDa |
| chr14_-_23285011 | 1.92 |
ENST00000397532.3
|
SLC7A7
|
solute carrier family 7 (amino acid transporter light chain, y+L system), member 7 |
| chr6_-_31745037 | 1.92 |
ENST00000375688.4
|
VWA7
|
von Willebrand factor A domain containing 7 |
| chr19_+_54496132 | 1.91 |
ENST00000346968.2
|
CACNG6
|
calcium channel, voltage-dependent, gamma subunit 6 |
| chr7_+_150076406 | 1.90 |
ENST00000329630.5
|
ZNF775
|
zinc finger protein 775 |
| chr11_+_114168085 | 1.88 |
ENST00000541754.1
|
NNMT
|
nicotinamide N-methyltransferase |
| chr3_+_98699880 | 1.87 |
ENST00000473756.1
|
LINC00973
|
long intergenic non-protein coding RNA 973 |
| chr16_+_84801852 | 1.86 |
ENST00000569925.1
ENST00000567526.1 |
USP10
|
ubiquitin specific peptidase 10 |
| chr7_+_99971068 | 1.85 |
ENST00000198536.2
ENST00000453419.1 |
PILRA
|
paired immunoglobin-like type 2 receptor alpha |
| chr8_-_27468842 | 1.85 |
ENST00000523500.1
|
CLU
|
clusterin |
| chr17_+_79935418 | 1.84 |
ENST00000306729.7
ENST00000306739.4 |
ASPSCR1
|
alveolar soft part sarcoma chromosome region, candidate 1 |
| chr17_-_34417479 | 1.84 |
ENST00000225245.5
|
CCL3
|
chemokine (C-C motif) ligand 3 |
| chr16_-_2260834 | 1.84 |
ENST00000562360.1
ENST00000566018.1 |
BRICD5
|
BRICHOS domain containing 5 |
| chr1_+_221051699 | 1.83 |
ENST00000366903.6
|
HLX
|
H2.0-like homeobox |
| chr3_+_15643245 | 1.83 |
ENST00000303498.5
ENST00000437172.1 |
BTD
|
biotinidase |
| chr2_-_233792837 | 1.80 |
ENST00000373552.4
ENST00000409079.1 |
NGEF
|
neuronal guanine nucleotide exchange factor |
| chr19_-_51875894 | 1.79 |
ENST00000600427.1
ENST00000595217.1 ENST00000221978.5 |
NKG7
|
natural killer cell group 7 sequence |
| chr10_+_89420706 | 1.79 |
ENST00000427144.2
|
PAPSS2
|
3'-phosphoadenosine 5'-phosphosulfate synthase 2 |
| chr1_-_153522562 | 1.78 |
ENST00000368714.1
|
S100A4
|
S100 calcium binding protein A4 |
| chr15_-_56757329 | 1.75 |
ENST00000260453.3
|
MNS1
|
meiosis-specific nuclear structural 1 |
| chr5_+_175298674 | 1.73 |
ENST00000514150.1
|
CPLX2
|
complexin 2 |
| chr16_+_31366455 | 1.73 |
ENST00000268296.4
|
ITGAX
|
integrin, alpha X (complement component 3 receptor 4 subunit) |
| chr20_-_33460621 | 1.72 |
ENST00000427420.1
ENST00000336431.5 |
GGT7
|
gamma-glutamyltransferase 7 |
| chr20_-_62129163 | 1.72 |
ENST00000298049.7
|
EEF1A2
|
eukaryotic translation elongation factor 1 alpha 2 |
| chrX_-_153707545 | 1.70 |
ENST00000357360.4
|
LAGE3
|
L antigen family, member 3 |
| chr11_+_66742742 | 1.69 |
ENST00000308963.4
|
C11orf86
|
chromosome 11 open reading frame 86 |
| chr1_-_23521222 | 1.69 |
ENST00000374619.1
|
HTR1D
|
5-hydroxytryptamine (serotonin) receptor 1D, G protein-coupled |
| chr8_+_76452097 | 1.69 |
ENST00000396423.2
|
HNF4G
|
hepatocyte nuclear factor 4, gamma |
| chr1_-_25291475 | 1.69 |
ENST00000338888.3
ENST00000399916.1 |
RUNX3
|
runt-related transcription factor 3 |
| chr4_-_140223614 | 1.68 |
ENST00000394223.1
|
NDUFC1
|
NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 1, 6kDa |
| chr20_-_23967432 | 1.67 |
ENST00000286890.4
ENST00000278765.4 |
GGTLC1
|
gamma-glutamyltransferase light chain 1 |
| chr8_-_27469196 | 1.66 |
ENST00000546343.1
ENST00000560566.1 |
CLU
|
clusterin |
| chr6_-_34524093 | 1.66 |
ENST00000544425.1
|
SPDEF
|
SAM pointed domain containing ETS transcription factor |
| chr17_-_19265982 | 1.66 |
ENST00000268841.6
ENST00000261499.4 ENST00000575478.1 |
B9D1
|
B9 protein domain 1 |
| chr8_-_27468945 | 1.64 |
ENST00000405140.3
|
CLU
|
clusterin |
| chr22_-_21580582 | 1.63 |
ENST00000424627.1
|
GGT2
|
gamma-glutamyltransferase 2 |
| chrX_-_54209640 | 1.61 |
ENST00000375180.2
ENST00000328235.4 ENST00000477084.1 |
FAM120C
|
family with sequence similarity 120C |
| chr1_+_149239529 | 1.60 |
ENST00000457216.2
|
RP11-403I13.4
|
RP11-403I13.4 |
| chr8_+_22436248 | 1.59 |
ENST00000308354.7
|
PDLIM2
|
PDZ and LIM domain 2 (mystique) |
| chr12_+_104697504 | 1.59 |
ENST00000527879.1
|
EID3
|
EP300 interacting inhibitor of differentiation 3 |
| chr17_+_27895609 | 1.59 |
ENST00000581411.2
ENST00000301057.7 |
TP53I13
|
tumor protein p53 inducible protein 13 |
| chr17_+_79935464 | 1.56 |
ENST00000581647.1
ENST00000580534.1 ENST00000579684.1 |
ASPSCR1
|
alveolar soft part sarcoma chromosome region, candidate 1 |
| chr5_-_43043272 | 1.56 |
ENST00000314890.3
|
ANXA2R
|
annexin A2 receptor |
| chr12_-_53343602 | 1.55 |
ENST00000546897.1
ENST00000552551.1 |
KRT8
|
keratin 8 |
| chr11_-_414948 | 1.55 |
ENST00000530494.1
ENST00000528209.1 ENST00000431843.2 ENST00000528058.1 |
SIGIRR
|
single immunoglobulin and toll-interleukin 1 receptor (TIR) domain |
| chr10_-_375422 | 1.54 |
ENST00000434695.2
|
DIP2C
|
DIP2 disco-interacting protein 2 homolog C (Drosophila) |
| chr15_-_55611306 | 1.52 |
ENST00000563262.1
|
RAB27A
|
RAB27A, member RAS oncogene family |
| chr1_-_21948906 | 1.52 |
ENST00000374761.2
ENST00000599760.1 |
RAP1GAP
|
RAP1 GTPase activating protein |
| chr20_+_61924532 | 1.50 |
ENST00000358894.6
ENST00000326996.6 ENST00000435874.1 |
COL20A1
|
collagen, type XX, alpha 1 |
| chr22_-_30642782 | 1.49 |
ENST00000249075.3
|
LIF
|
leukemia inhibitory factor |
| chr7_+_139025875 | 1.47 |
ENST00000297534.6
|
C7orf55
|
chromosome 7 open reading frame 55 |
| chr17_-_47045949 | 1.47 |
ENST00000357424.2
|
GIP
|
gastric inhibitory polypeptide |
| chr14_+_58711539 | 1.47 |
ENST00000216455.4
ENST00000412908.2 ENST00000557508.1 |
PSMA3
|
proteasome (prosome, macropain) subunit, alpha type, 3 |
| chr2_+_103035102 | 1.46 |
ENST00000264260.2
|
IL18RAP
|
interleukin 18 receptor accessory protein |
| chr22_-_42342692 | 1.46 |
ENST00000404067.1
ENST00000402338.1 |
CENPM
|
centromere protein M |
| chr19_-_40440533 | 1.44 |
ENST00000221347.6
|
FCGBP
|
Fc fragment of IgG binding protein |
| chr19_+_17413663 | 1.44 |
ENST00000594999.1
|
MRPL34
|
mitochondrial ribosomal protein L34 |
| chr14_+_21152706 | 1.43 |
ENST00000397995.2
ENST00000304704.4 ENST00000553909.1 |
RNASE4
AL163636.6
|
ribonuclease, RNase A family, 4 Homo sapiens ribonuclease, RNase A family, 4 (RNASE4), transcript variant 4, mRNA. |
| chr8_-_27468717 | 1.42 |
ENST00000520796.1
ENST00000520491.1 |
CLU
|
clusterin |
| chr20_-_25062767 | 1.42 |
ENST00000429762.3
ENST00000444511.2 ENST00000376707.3 |
VSX1
|
visual system homeobox 1 |
| chr15_+_50474385 | 1.42 |
ENST00000267842.5
|
SLC27A2
|
solute carrier family 27 (fatty acid transporter), member 2 |
| chr1_+_1217489 | 1.41 |
ENST00000325425.8
ENST00000400928.3 |
SCNN1D
|
sodium channel, non-voltage-gated 1, delta subunit |
| chr14_-_94789663 | 1.41 |
ENST00000557225.1
ENST00000341584.3 |
SERPINA6
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 6 |
| chr6_-_107235331 | 1.41 |
ENST00000433965.1
ENST00000430094.1 |
RP1-60O19.1
|
RP1-60O19.1 |
| chr10_+_91152303 | 1.40 |
ENST00000371804.3
|
IFIT1
|
interferon-induced protein with tetratricopeptide repeats 1 |
| chr17_+_47075023 | 1.40 |
ENST00000431824.2
|
IGF2BP1
|
insulin-like growth factor 2 mRNA binding protein 1 |
| chr22_+_44464923 | 1.39 |
ENST00000404989.1
|
PARVB
|
parvin, beta |
| chr9_+_131902346 | 1.39 |
ENST00000432124.1
ENST00000435305.1 |
PPP2R4
|
protein phosphatase 2A activator, regulatory subunit 4 |
| chr14_-_23791484 | 1.39 |
ENST00000594872.1
|
AL049829.1
|
Uncharacterized protein |
| chr7_-_27183263 | 1.38 |
ENST00000222726.3
|
HOXA5
|
homeobox A5 |
| chr10_+_112404132 | 1.38 |
ENST00000369519.3
|
RBM20
|
RNA binding motif protein 20 |
| chrX_-_153707246 | 1.37 |
ENST00000407062.1
|
LAGE3
|
L antigen family, member 3 |
| chr1_+_201979743 | 1.37 |
ENST00000446188.1
|
ELF3
|
E74-like factor 3 (ets domain transcription factor, epithelial-specific ) |
| chrX_-_151143140 | 1.35 |
ENST00000393914.3
ENST00000370328.3 ENST00000370325.1 |
GABRE
|
gamma-aminobutyric acid (GABA) A receptor, epsilon |
| chrX_-_55208866 | 1.35 |
ENST00000545075.1
|
MTRNR2L10
|
MT-RNR2-like 10 |
| chr16_-_1821721 | 1.35 |
ENST00000219302.3
|
NME3
|
NME/NM23 nucleoside diphosphate kinase 3 |
| chr12_-_7245125 | 1.34 |
ENST00000542285.1
ENST00000540610.1 |
C1R
|
complement component 1, r subcomponent |
| chr2_-_99917639 | 1.34 |
ENST00000308528.4
|
LYG1
|
lysozyme G-like 1 |
| chr11_+_2923619 | 1.33 |
ENST00000380574.1
|
SLC22A18
|
solute carrier family 22, member 18 |
| chr15_-_74494779 | 1.33 |
ENST00000571341.1
|
STRA6
|
stimulated by retinoic acid 6 |
| chr9_+_118916082 | 1.33 |
ENST00000328252.3
|
PAPPA
|
pregnancy-associated plasma protein A, pappalysin 1 |
| chr15_+_50474412 | 1.32 |
ENST00000380902.4
|
SLC27A2
|
solute carrier family 27 (fatty acid transporter), member 2 |
| chr2_+_101591314 | 1.32 |
ENST00000450763.1
|
NPAS2
|
neuronal PAS domain protein 2 |
| chr19_-_55919087 | 1.31 |
ENST00000587845.1
ENST00000589978.1 ENST00000264552.9 |
UBE2S
|
ubiquitin-conjugating enzyme E2S |
| chr8_+_145162629 | 1.31 |
ENST00000323662.8
|
KIAA1875
|
KIAA1875 |
| chr22_-_42343117 | 1.30 |
ENST00000407253.3
ENST00000215980.5 |
CENPM
|
centromere protein M |
| chr17_-_3495644 | 1.29 |
ENST00000310522.5
ENST00000425167.2 ENST00000576351.1 |
TRPV1
|
transient receptor potential cation channel, subfamily V, member 1 |
| chr6_-_30710447 | 1.29 |
ENST00000456573.2
|
FLOT1
|
flotillin 1 |
| chr2_+_136499287 | 1.29 |
ENST00000415164.1
|
UBXN4
|
UBX domain protein 4 |
| chr10_+_134258649 | 1.29 |
ENST00000392630.3
ENST00000321248.2 |
C10orf91
|
chromosome 10 open reading frame 91 |
| chr12_-_53343560 | 1.28 |
ENST00000548998.1
|
KRT8
|
keratin 8 |
| chr2_+_175199674 | 1.28 |
ENST00000394967.2
|
SP9
|
Sp9 transcription factor |
| chr22_+_39378375 | 1.28 |
ENST00000402182.3
ENST00000333467.3 |
APOBEC3B
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B |
| chr17_-_53046058 | 1.28 |
ENST00000571584.1
ENST00000299335.3 |
COX11
|
cytochrome c oxidase assembly homolog 11 (yeast) |
| chr3_+_15643476 | 1.27 |
ENST00000436193.1
ENST00000383778.4 |
BTD
|
biotinidase |
| chr12_+_20968608 | 1.27 |
ENST00000381541.3
ENST00000540229.1 ENST00000553473.1 ENST00000554957.1 |
LST3
SLCO1B3
SLCO1B7
|
Putative solute carrier organic anion transporter family member 1B7; Uncharacterized protein solute carrier organic anion transporter family, member 1B3 solute carrier organic anion transporter family, member 1B7 (non-functional) |
| chr1_-_24469602 | 1.26 |
ENST00000270800.1
|
IL22RA1
|
interleukin 22 receptor, alpha 1 |
| chr9_+_139846708 | 1.25 |
ENST00000371633.3
|
LCN12
|
lipocalin 12 |
| chr11_-_67141640 | 1.25 |
ENST00000533438.1
|
CLCF1
|
cardiotrophin-like cytokine factor 1 |
| chr19_-_39322497 | 1.24 |
ENST00000221418.4
|
ECH1
|
enoyl CoA hydratase 1, peroxisomal |
| chr12_-_53574418 | 1.24 |
ENST00000379843.3
ENST00000453446.2 ENST00000437073.1 |
CSAD
|
cysteine sulfinic acid decarboxylase |
| chr12_+_54422142 | 1.23 |
ENST00000243108.4
|
HOXC6
|
homeobox C6 |
| chr14_-_23284703 | 1.23 |
ENST00000555911.1
|
SLC7A7
|
solute carrier family 7 (amino acid transporter light chain, y+L system), member 7 |
| chr1_+_149871171 | 1.22 |
ENST00000369150.1
|
BOLA1
|
bolA family member 1 |
| chr19_+_3708376 | 1.21 |
ENST00000539908.2
|
TJP3
|
tight junction protein 3 |
| chr11_-_67141090 | 1.21 |
ENST00000312438.7
|
CLCF1
|
cardiotrophin-like cytokine factor 1 |
| chr17_+_72427477 | 1.21 |
ENST00000342648.5
ENST00000481232.1 |
GPRC5C
|
G protein-coupled receptor, family C, group 5, member C |
| chrX_-_100129128 | 1.20 |
ENST00000372960.4
ENST00000372964.1 ENST00000217885.5 |
NOX1
|
NADPH oxidase 1 |
| chr6_+_27925019 | 1.20 |
ENST00000244623.1
|
OR2B6
|
olfactory receptor, family 2, subfamily B, member 6 |
| chr19_+_11466062 | 1.20 |
ENST00000251473.5
ENST00000591329.1 ENST00000586380.1 |
DKFZP761J1410
|
Lipid phosphate phosphatase-related protein type 2 |
| chr12_-_53574376 | 1.20 |
ENST00000267085.4
ENST00000379850.3 ENST00000379846.1 ENST00000424990.1 |
CSAD
|
cysteine sulfinic acid decarboxylase |
| chr11_+_65337901 | 1.20 |
ENST00000309328.3
ENST00000531405.1 ENST00000527920.1 ENST00000526877.1 ENST00000533115.1 ENST00000526433.1 |
SSSCA1
|
Sjogren syndrome/scleroderma autoantigen 1 |
| chr3_+_15643140 | 1.19 |
ENST00000449107.1
|
BTD
|
biotinidase |
| chr3_-_12200851 | 1.19 |
ENST00000287814.4
|
TIMP4
|
TIMP metallopeptidase inhibitor 4 |
| chr2_+_234296792 | 1.19 |
ENST00000409813.3
|
DGKD
|
diacylglycerol kinase, delta 130kDa |
| chr16_-_30022735 | 1.19 |
ENST00000564944.1
|
DOC2A
|
double C2-like domains, alpha |
Network of associatons between targets according to the STRING database.
First level regulatory network of RUNX1_RUNX2
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.2 | 9.6 | GO:2000502 | negative regulation of natural killer cell chemotaxis(GO:2000502) |
| 2.2 | 6.5 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
| 1.8 | 7.2 | GO:2000866 | positive regulation of estrogen secretion(GO:2000863) positive regulation of estradiol secretion(GO:2000866) |
| 1.2 | 3.6 | GO:2000196 | positive regulation of female gonad development(GO:2000196) |
| 0.9 | 16.7 | GO:1901750 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
| 0.9 | 8.3 | GO:0046618 | drug export(GO:0046618) |
| 0.9 | 7.2 | GO:0050653 | chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
| 0.9 | 4.4 | GO:0015891 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
| 0.8 | 6.6 | GO:1902998 | regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
| 0.8 | 5.3 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
| 0.7 | 3.0 | GO:0035483 | gastric motility(GO:0035482) gastric emptying(GO:0035483) |
| 0.7 | 14.5 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
| 0.7 | 8.0 | GO:0030259 | lipid glycosylation(GO:0030259) |
| 0.6 | 1.9 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
| 0.6 | 2.3 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
| 0.6 | 5.7 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
| 0.5 | 2.7 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
| 0.5 | 2.7 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
| 0.5 | 3.2 | GO:0051673 | membrane disruption in other organism(GO:0051673) |
| 0.5 | 0.5 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
| 0.5 | 1.5 | GO:1903697 | negative regulation of microvillus assembly(GO:1903697) |
| 0.5 | 2.4 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
| 0.5 | 4.3 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
| 0.5 | 1.4 | GO:1904204 | regulation of skeletal muscle hypertrophy(GO:1904204) |
| 0.5 | 2.8 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
| 0.5 | 1.4 | GO:2001226 | negative regulation of chloride transport(GO:2001226) |
| 0.4 | 1.8 | GO:0000103 | sulfate assimilation(GO:0000103) |
| 0.4 | 1.8 | GO:0045726 | positive regulation of integrin biosynthetic process(GO:0045726) |
| 0.4 | 1.8 | GO:0061760 | antifungal innate immune response(GO:0061760) |
| 0.4 | 2.2 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
| 0.4 | 1.7 | GO:0002432 | granuloma formation(GO:0002432) |
| 0.4 | 1.7 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
| 0.4 | 1.2 | GO:1903217 | negative regulation of late endosome to lysosome transport(GO:1902823) regulation of protein processing involved in protein targeting to mitochondrion(GO:1903216) negative regulation of protein processing involved in protein targeting to mitochondrion(GO:1903217) |
| 0.4 | 1.6 | GO:1901594 | detection of temperature stimulus involved in thermoception(GO:0050960) response to capsazepine(GO:1901594) |
| 0.4 | 2.0 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
| 0.4 | 9.2 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
| 0.4 | 0.8 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.4 | 1.5 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
| 0.4 | 2.7 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
| 0.4 | 1.1 | GO:0048210 | Golgi vesicle fusion to target membrane(GO:0048210) |
| 0.4 | 1.1 | GO:0010621 | negative regulation of transcription by transcription factor localization(GO:0010621) |
| 0.4 | 2.2 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
| 0.4 | 2.2 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
| 0.4 | 2.2 | GO:0015887 | biotin transport(GO:0015878) pantothenate transmembrane transport(GO:0015887) |
| 0.4 | 1.1 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
| 0.4 | 1.1 | GO:0050955 | thermoception(GO:0050955) |
| 0.3 | 1.4 | GO:0051097 | negative regulation of helicase activity(GO:0051097) |
| 0.3 | 5.8 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
| 0.3 | 0.7 | GO:0050772 | positive regulation of axonogenesis(GO:0050772) |
| 0.3 | 1.3 | GO:0090345 | cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
| 0.3 | 1.3 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
| 0.3 | 1.0 | GO:0032581 | ER-dependent peroxisome organization(GO:0032581) |
| 0.3 | 0.6 | GO:1990927 | calcium ion regulated lysosome exocytosis(GO:1990927) |
| 0.3 | 6.5 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
| 0.3 | 1.5 | GO:0018057 | peptidyl-lysine oxidation(GO:0018057) |
| 0.3 | 2.4 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
| 0.3 | 0.3 | GO:0048733 | sebaceous gland development(GO:0048733) |
| 0.3 | 2.7 | GO:1904636 | response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
| 0.3 | 1.5 | GO:0030501 | positive regulation of bone mineralization(GO:0030501) |
| 0.3 | 0.9 | GO:0050760 | negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
| 0.3 | 1.2 | GO:1904106 | protein localization to microvillus(GO:1904106) |
| 0.3 | 2.0 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
| 0.3 | 4.0 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
| 0.3 | 0.8 | GO:0034130 | toll-like receptor 1 signaling pathway(GO:0034130) |
| 0.3 | 1.1 | GO:0001189 | RNA polymerase I transcriptional preinitiation complex assembly(GO:0001188) RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript(GO:0001189) |
| 0.3 | 0.8 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
| 0.3 | 0.5 | GO:1990051 | activation of protein kinase C activity(GO:1990051) |
| 0.3 | 0.8 | GO:0043095 | regulation of GTP cyclohydrolase I activity(GO:0043095) negative regulation of GTP cyclohydrolase I activity(GO:0043105) |
| 0.3 | 0.8 | GO:2000705 | dense core granule biogenesis(GO:0061110) regulation of dense core granule biogenesis(GO:2000705) |
| 0.3 | 1.0 | GO:0019442 | tryptophan catabolic process to acetyl-CoA(GO:0019442) |
| 0.3 | 1.0 | GO:0044537 | regulation of circulating fibrinogen levels(GO:0044537) |
| 0.3 | 1.0 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
| 0.2 | 3.7 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
| 0.2 | 4.0 | GO:0046149 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.2 | 5.1 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
| 0.2 | 1.0 | GO:0007343 | egg activation(GO:0007343) |
| 0.2 | 1.0 | GO:0002268 | follicular dendritic cell differentiation(GO:0002268) |
| 0.2 | 1.4 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
| 0.2 | 2.4 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 0.2 | 0.9 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
| 0.2 | 0.9 | GO:0070845 | misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
| 0.2 | 0.9 | GO:0052026 | modulation by virus of host transcription(GO:0019056) positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) modulation by symbiont of host transcription(GO:0052026) |
| 0.2 | 6.9 | GO:0032060 | bleb assembly(GO:0032060) |
| 0.2 | 1.1 | GO:0098502 | DNA dephosphorylation(GO:0098502) |
| 0.2 | 0.9 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
| 0.2 | 0.9 | GO:0002503 | peptide antigen assembly with MHC class II protein complex(GO:0002503) |
| 0.2 | 2.0 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
| 0.2 | 1.3 | GO:0061143 | alveolar primary septum development(GO:0061143) |
| 0.2 | 1.6 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
| 0.2 | 0.2 | GO:0072678 | T cell migration(GO:0072678) |
| 0.2 | 2.2 | GO:0071569 | protein ufmylation(GO:0071569) |
| 0.2 | 1.5 | GO:1903435 | positive regulation of constitutive secretory pathway(GO:1903435) |
| 0.2 | 1.1 | GO:0036511 | trimming of terminal mannose on B branch(GO:0036509) trimming of first mannose on A branch(GO:0036511) trimming of second mannose on A branch(GO:0036512) |
| 0.2 | 1.1 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
| 0.2 | 1.3 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.2 | 0.6 | GO:0060721 | spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
| 0.2 | 1.5 | GO:0070091 | glucagon secretion(GO:0070091) regulation of glucagon secretion(GO:0070092) |
| 0.2 | 1.9 | GO:0030043 | actin filament fragmentation(GO:0030043) |
| 0.2 | 0.2 | GO:2001190 | positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:2001190) |
| 0.2 | 2.0 | GO:0018406 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 0.2 | 1.2 | GO:1902460 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 0.2 | 0.2 | GO:0014839 | myoblast migration involved in skeletal muscle regeneration(GO:0014839) |
| 0.2 | 1.0 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
| 0.2 | 1.6 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
| 0.2 | 1.4 | GO:0060056 | mammary gland involution(GO:0060056) |
| 0.2 | 0.4 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) |
| 0.2 | 0.8 | GO:0003289 | atrial septum primum morphogenesis(GO:0003289) |
| 0.2 | 2.9 | GO:0006782 | protoporphyrinogen IX biosynthetic process(GO:0006782) |
| 0.2 | 2.1 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
| 0.2 | 0.8 | GO:0050712 | negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
| 0.2 | 2.4 | GO:0032306 | regulation of prostaglandin secretion(GO:0032306) positive regulation of prostaglandin secretion(GO:0032308) |
| 0.2 | 0.6 | GO:0007057 | spindle assembly involved in female meiosis I(GO:0007057) |
| 0.2 | 0.9 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
| 0.2 | 1.8 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
| 0.2 | 4.0 | GO:0006768 | biotin metabolic process(GO:0006768) |
| 0.2 | 2.7 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) negative regulation of relaxation of cardiac muscle(GO:1901898) |
| 0.2 | 0.7 | GO:0060032 | notochord regression(GO:0060032) |
| 0.2 | 0.5 | GO:0070105 | positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
| 0.2 | 1.0 | GO:0033594 | response to hydroxyisoflavone(GO:0033594) |
| 0.2 | 1.4 | GO:0071104 | response to interleukin-9(GO:0071104) |
| 0.2 | 0.5 | GO:0006173 | dADP biosynthetic process(GO:0006173) |
| 0.2 | 0.8 | GO:0071934 | thiamine transmembrane transport(GO:0071934) |
| 0.2 | 1.9 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 0.2 | 1.1 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
| 0.2 | 1.0 | GO:0035407 | histone H3-T11 phosphorylation(GO:0035407) |
| 0.2 | 0.5 | GO:0060381 | regulation of single-stranded telomeric DNA binding(GO:0060380) positive regulation of single-stranded telomeric DNA binding(GO:0060381) |
| 0.2 | 0.8 | GO:0052056 | modulation by virus of host molecular function(GO:0039506) suppression by virus of host molecular function(GO:0039507) suppression by virus of host catalytic activity(GO:0039513) modulation by virus of host catalytic activity(GO:0039516) suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process(GO:0039650) negative regulation by symbiont of host catalytic activity(GO:0052053) negative regulation by symbiont of host molecular function(GO:0052056) modulation by symbiont of host catalytic activity(GO:0052148) |
| 0.2 | 1.9 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.2 | 2.2 | GO:0044849 | estrous cycle(GO:0044849) |
| 0.2 | 0.6 | GO:0072287 | metanephric distal tubule morphogenesis(GO:0072287) |
| 0.2 | 0.5 | GO:0045799 | positive regulation of chromatin assembly or disassembly(GO:0045799) |
| 0.2 | 0.6 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) positive regulation of interferon-alpha biosynthetic process(GO:0045356) negative regulation of calcium-transporting ATPase activity(GO:1901895) |
| 0.2 | 0.6 | GO:1904457 | beta-glucoside metabolic process(GO:1901804) beta-glucoside catabolic process(GO:1901805) positive regulation of neuronal action potential(GO:1904457) |
| 0.2 | 0.6 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
| 0.2 | 0.2 | GO:0052199 | negative regulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052199) |
| 0.2 | 1.1 | GO:1903416 | response to glycoside(GO:1903416) |
| 0.2 | 1.2 | GO:0009253 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
| 0.2 | 2.4 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
| 0.2 | 1.8 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
| 0.1 | 0.6 | GO:1902499 | positive regulation of protein autoubiquitination(GO:1902499) |
| 0.1 | 0.7 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
| 0.1 | 0.7 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.1 | 0.9 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
| 0.1 | 0.7 | GO:0032456 | endocytic recycling(GO:0032456) |
| 0.1 | 0.6 | GO:1903803 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
| 0.1 | 0.6 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
| 0.1 | 0.7 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
| 0.1 | 0.4 | GO:0060796 | regulation of transcription involved in primary germ layer cell fate commitment(GO:0060796) |
| 0.1 | 1.1 | GO:0034392 | negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
| 0.1 | 0.3 | GO:0044179 | hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
| 0.1 | 3.0 | GO:0070914 | UV-damage excision repair(GO:0070914) |
| 0.1 | 0.6 | GO:0042264 | peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 0.1 | 1.1 | GO:0009753 | response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
| 0.1 | 2.2 | GO:0030238 | male sex determination(GO:0030238) |
| 0.1 | 0.4 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
| 0.1 | 9.6 | GO:0050999 | regulation of nitric-oxide synthase activity(GO:0050999) |
| 0.1 | 0.5 | GO:0035711 | T-helper 1 cell activation(GO:0035711) |
| 0.1 | 0.3 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
| 0.1 | 2.3 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
| 0.1 | 0.7 | GO:1904844 | response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
| 0.1 | 0.7 | GO:0008343 | adult feeding behavior(GO:0008343) |
| 0.1 | 0.5 | GO:1900133 | regulation of renin secretion into blood stream(GO:1900133) |
| 0.1 | 0.1 | GO:0097534 | lymphoid lineage cell migration(GO:0097534) lymphoid lineage cell migration into thymus(GO:0097535) |
| 0.1 | 0.3 | GO:2000870 | regulation of progesterone secretion(GO:2000870) |
| 0.1 | 0.6 | GO:0006203 | dGTP catabolic process(GO:0006203) |
| 0.1 | 0.4 | GO:0051541 | elastin metabolic process(GO:0051541) |
| 0.1 | 0.4 | GO:1902808 | positive regulation of cell cycle G1/S phase transition(GO:1902808) |
| 0.1 | 0.6 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
| 0.1 | 0.5 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.1 | 1.4 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
| 0.1 | 0.8 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
| 0.1 | 1.0 | GO:0006880 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
| 0.1 | 0.9 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
| 0.1 | 0.5 | GO:0035995 | skeletal muscle myosin thick filament assembly(GO:0030241) detection of muscle stretch(GO:0035995) |
| 0.1 | 1.2 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
| 0.1 | 1.0 | GO:0000066 | mitochondrial ornithine transport(GO:0000066) |
| 0.1 | 0.7 | GO:0036309 | protein localization to M-band(GO:0036309) |
| 0.1 | 0.2 | GO:0032310 | prostaglandin secretion(GO:0032310) |
| 0.1 | 0.5 | GO:0071348 | response to interleukin-11(GO:0071105) cellular response to interleukin-11(GO:0071348) |
| 0.1 | 0.1 | GO:1904640 | response to methionine(GO:1904640) |
| 0.1 | 1.0 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
| 0.1 | 1.9 | GO:0006108 | malate metabolic process(GO:0006108) |
| 0.1 | 0.4 | GO:1901846 | positive regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901846) |
| 0.1 | 2.2 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
| 0.1 | 0.6 | GO:0003095 | pressure natriuresis(GO:0003095) vitamin E metabolic process(GO:0042360) |
| 0.1 | 0.9 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
| 0.1 | 2.5 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
| 0.1 | 2.0 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.1 | 0.8 | GO:2001033 | negative regulation of double-strand break repair via nonhomologous end joining(GO:2001033) |
| 0.1 | 0.3 | GO:0038178 | complement component C5a signaling pathway(GO:0038178) |
| 0.1 | 0.3 | GO:0016999 | antibiotic metabolic process(GO:0016999) |
| 0.1 | 0.9 | GO:0045007 | depurination(GO:0045007) |
| 0.1 | 0.3 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.1 | 0.3 | GO:1990697 | protein depalmitoleylation(GO:1990697) |
| 0.1 | 0.3 | GO:1902303 | regulation of heart rate by hormone(GO:0003064) negative regulation of potassium ion export(GO:1902303) |
| 0.1 | 0.3 | GO:1904924 | negative regulation of mitophagy in response to mitochondrial depolarization(GO:1904924) |
| 0.1 | 0.4 | GO:0036034 | mediator complex assembly(GO:0036034) regulation of mediator complex assembly(GO:2001176) positive regulation of mediator complex assembly(GO:2001178) |
| 0.1 | 0.3 | GO:0034552 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
| 0.1 | 0.3 | GO:1904597 | regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904596) negative regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904597) regulation of advanced glycation end-product receptor activity(GO:1904603) negative regulation of advanced glycation end-product receptor activity(GO:1904604) negative regulation of connective tissue replacement(GO:1905204) |
| 0.1 | 1.1 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.1 | 0.4 | GO:2000259 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
| 0.1 | 0.6 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
| 0.1 | 0.5 | GO:0070173 | regulation of enamel mineralization(GO:0070173) |
| 0.1 | 0.3 | GO:0036333 | hepatocyte homeostasis(GO:0036333) response to tetrachloromethane(GO:1904772) |
| 0.1 | 2.0 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.1 | 2.0 | GO:1901678 | iron coordination entity transport(GO:1901678) |
| 0.1 | 0.3 | GO:0002879 | leukocyte chemotaxis involved in inflammatory response(GO:0002232) positive regulation of acute inflammatory response to non-antigenic stimulus(GO:0002879) |
| 0.1 | 0.3 | GO:0070408 | carbamoyl phosphate metabolic process(GO:0070408) carbamoyl phosphate biosynthetic process(GO:0070409) response to ammonia(GO:1903717) cellular response to ammonia(GO:1903718) |
| 0.1 | 1.4 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
| 0.1 | 0.4 | GO:0061591 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
| 0.1 | 0.3 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) positive regulation of fibrinolysis(GO:0051919) |
| 0.1 | 2.0 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
| 0.1 | 0.5 | GO:0010730 | negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
| 0.1 | 0.4 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
| 0.1 | 0.8 | GO:0002863 | positive regulation of inflammatory response to antigenic stimulus(GO:0002863) |
| 0.1 | 2.0 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
| 0.1 | 0.4 | GO:0072717 | cellular response to actinomycin D(GO:0072717) |
| 0.1 | 0.6 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
| 0.1 | 0.3 | GO:0034343 | type III interferon production(GO:0034343) regulation of type III interferon production(GO:0034344) |
| 0.1 | 0.1 | GO:0001798 | positive regulation of type IIa hypersensitivity(GO:0001798) positive regulation of type II hypersensitivity(GO:0002894) |
| 0.1 | 1.2 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
| 0.1 | 0.6 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
| 0.1 | 0.3 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
| 0.1 | 0.9 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
| 0.1 | 0.4 | GO:1901837 | negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
| 0.1 | 0.5 | GO:0019303 | D-ribose catabolic process(GO:0019303) |
| 0.1 | 0.5 | GO:0007525 | somatic muscle development(GO:0007525) |
| 0.1 | 1.3 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
| 0.1 | 1.0 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
| 0.1 | 0.3 | GO:1903988 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) spleen trabecula formation(GO:0060345) iron cation export(GO:1903414) ferrous iron export(GO:1903988) |
| 0.1 | 0.1 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
| 0.1 | 0.5 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
| 0.1 | 0.3 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
| 0.1 | 0.9 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
| 0.1 | 0.5 | GO:0045638 | negative regulation of myeloid cell differentiation(GO:0045638) |
| 0.1 | 0.4 | GO:0015862 | uridine transport(GO:0015862) |
| 0.1 | 0.7 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
| 0.1 | 0.5 | GO:0019441 | tryptophan metabolic process(GO:0006568) tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
| 0.1 | 3.6 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
| 0.1 | 0.4 | GO:0043010 | camera-type eye development(GO:0043010) |
| 0.1 | 0.9 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
| 0.1 | 0.7 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
| 0.1 | 0.8 | GO:0046415 | urate metabolic process(GO:0046415) |
| 0.1 | 0.5 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
| 0.1 | 0.3 | GO:0031133 | regulation of axon diameter(GO:0031133) |
| 0.1 | 1.6 | GO:0019532 | oxalate transport(GO:0019532) |
| 0.1 | 0.9 | GO:0043507 | positive regulation of JUN kinase activity(GO:0043507) |
| 0.1 | 0.5 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
| 0.1 | 0.2 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
| 0.1 | 0.2 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
| 0.1 | 0.1 | GO:0002589 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) |
| 0.1 | 1.4 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
| 0.1 | 0.4 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
| 0.1 | 1.0 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
| 0.1 | 1.4 | GO:0045023 | G0 to G1 transition(GO:0045023) |
| 0.1 | 2.2 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
| 0.1 | 3.3 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
| 0.1 | 0.2 | GO:0001694 | histamine biosynthetic process(GO:0001694) |
| 0.1 | 0.7 | GO:0021840 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) |
| 0.1 | 1.2 | GO:0043313 | regulation of neutrophil degranulation(GO:0043313) |
| 0.1 | 0.2 | GO:1903251 | multi-ciliated epithelial cell differentiation(GO:1903251) |
| 0.1 | 0.9 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.1 | 0.2 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
| 0.1 | 0.2 | GO:0002416 | IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
| 0.1 | 1.0 | GO:0015889 | cobalamin transport(GO:0015889) |
| 0.1 | 0.2 | GO:1904616 | regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 0.1 | 0.5 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
| 0.1 | 0.9 | GO:0031294 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
| 0.1 | 1.1 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
| 0.1 | 0.4 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
| 0.1 | 1.1 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
| 0.1 | 0.1 | GO:0007538 | primary sex determination(GO:0007538) |
| 0.1 | 0.1 | GO:0019627 | urea cycle(GO:0000050) urea metabolic process(GO:0019627) |
| 0.1 | 0.9 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.1 | 0.3 | GO:0086097 | phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
| 0.1 | 0.1 | GO:2000360 | negative regulation of binding of sperm to zona pellucida(GO:2000360) |
| 0.1 | 0.3 | GO:0034214 | protein hexamerization(GO:0034214) |
| 0.1 | 0.3 | GO:0009213 | pyrimidine nucleoside triphosphate catabolic process(GO:0009149) pyrimidine deoxyribonucleoside triphosphate catabolic process(GO:0009213) |
| 0.1 | 1.7 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
| 0.1 | 0.4 | GO:0007270 | neuron-neuron synaptic transmission(GO:0007270) |
| 0.1 | 0.3 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
| 0.1 | 0.6 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
| 0.1 | 0.3 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
| 0.1 | 0.3 | GO:0006527 | arginine catabolic process(GO:0006527) |
| 0.1 | 1.3 | GO:0051775 | response to redox state(GO:0051775) |
| 0.1 | 0.7 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
| 0.1 | 4.7 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.1 | 0.5 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
| 0.1 | 0.1 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
| 0.1 | 0.2 | GO:0051881 | regulation of mitochondrial membrane potential(GO:0051881) |
| 0.1 | 0.6 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 0.1 | 0.2 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
| 0.1 | 1.6 | GO:1903541 | regulation of exosomal secretion(GO:1903541) |
| 0.1 | 0.3 | GO:1904835 | vestibulocochlear nerve structural organization(GO:0021649) positive regulation of cytokine activity(GO:0060301) renal artery morphogenesis(GO:0061441) ganglion morphogenesis(GO:0061552) VEGF-activated neuropilin signaling pathway involved in axon guidance(GO:1902378) dorsal root ganglion morphogenesis(GO:1904835) otic placode development(GO:1905040) |
| 0.1 | 0.5 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) |
| 0.1 | 1.5 | GO:0070986 | left/right axis specification(GO:0070986) |
| 0.1 | 0.3 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
| 0.1 | 0.4 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
| 0.1 | 0.1 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
| 0.1 | 0.4 | GO:0071926 | endocannabinoid signaling pathway(GO:0071926) regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.1 | 0.1 | GO:0071613 | granzyme B production(GO:0071613) regulation of granzyme B production(GO:0071661) positive regulation of granzyme B production(GO:0071663) |
| 0.1 | 0.6 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
| 0.1 | 0.2 | GO:2000977 | regulation of primitive erythrocyte differentiation(GO:0010725) eosinophil fate commitment(GO:0035854) regulation of forebrain neuron differentiation(GO:2000977) |
| 0.1 | 1.1 | GO:0097502 | mannosylation(GO:0097502) |
| 0.1 | 1.9 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
| 0.1 | 1.3 | GO:0006554 | lysine catabolic process(GO:0006554) |
| 0.1 | 0.5 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
| 0.1 | 0.2 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
| 0.1 | 0.2 | GO:0030261 | chromosome condensation(GO:0030261) |
| 0.1 | 0.3 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
| 0.1 | 0.4 | GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
| 0.1 | 0.2 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
| 0.1 | 4.6 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
| 0.1 | 12.1 | GO:0002223 | stimulatory C-type lectin receptor signaling pathway(GO:0002223) |
| 0.1 | 0.4 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.1 | 0.5 | GO:0071918 | urea transmembrane transport(GO:0071918) |
| 0.1 | 0.4 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.1 | 0.2 | GO:0072248 | metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
| 0.1 | 0.2 | GO:0002625 | regulation of T cell antigen processing and presentation(GO:0002625) |
| 0.1 | 0.2 | GO:1903564 | regulation of protein localization to cilium(GO:1903564) negative regulation of protein localization to cilium(GO:1903565) regulation of protein localization to ciliary membrane(GO:1903567) negative regulation of protein localization to ciliary membrane(GO:1903568) |
| 0.1 | 0.6 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
| 0.1 | 0.4 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.1 | 0.6 | GO:1904781 | positive regulation of protein localization to centrosome(GO:1904781) |
| 0.1 | 1.3 | GO:0032354 | response to follicle-stimulating hormone(GO:0032354) |
| 0.1 | 1.5 | GO:0033500 | carbohydrate homeostasis(GO:0033500) glucose homeostasis(GO:0042593) |
| 0.1 | 0.5 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
| 0.1 | 0.1 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
| 0.1 | 0.6 | GO:0070307 | Bergmann glial cell differentiation(GO:0060020) lens fiber cell development(GO:0070307) |
| 0.1 | 4.8 | GO:0030449 | regulation of complement activation(GO:0030449) |
| 0.1 | 0.2 | GO:0086021 | SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) |
| 0.1 | 0.3 | GO:0055009 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
| 0.1 | 0.3 | GO:0032536 | regulation of cell projection size(GO:0032536) |
| 0.1 | 0.9 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
| 0.1 | 0.2 | GO:1902943 | positive regulation of cyclic nucleotide-gated ion channel activity(GO:1902161) regulation of voltage-gated chloride channel activity(GO:1902941) positive regulation of voltage-gated chloride channel activity(GO:1902943) |
| 0.1 | 0.7 | GO:0045780 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
| 0.1 | 0.4 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
| 0.1 | 2.4 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
| 0.1 | 0.1 | GO:2000053 | regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) |
| 0.1 | 2.4 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.1 | 0.5 | GO:1901970 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of mitotic sister chromatid separation(GO:1901970) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
| 0.1 | 0.3 | GO:0030573 | bile acid catabolic process(GO:0030573) |
| 0.1 | 0.4 | GO:0003322 | pancreatic A cell development(GO:0003322) |
| 0.1 | 0.3 | GO:0000429 | carbon catabolite regulation of transcription from RNA polymerase II promoter(GO:0000429) carbon catabolite activation of transcription from RNA polymerase II promoter(GO:0000436) negative regulation of fibrinolysis(GO:0051918) |
| 0.1 | 0.3 | GO:0001771 | immunological synapse formation(GO:0001771) |
| 0.1 | 0.2 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
| 0.1 | 0.8 | GO:0015866 | ADP transport(GO:0015866) |
| 0.1 | 0.5 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
| 0.0 | 0.2 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.0 | 0.1 | GO:0060981 | cell migration involved in coronary angiogenesis(GO:0060981) |
| 0.0 | 0.1 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
| 0.0 | 0.2 | GO:1904882 | telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
| 0.0 | 0.4 | GO:0043932 | ossification involved in bone remodeling(GO:0043932) |
| 0.0 | 0.2 | GO:0045872 | positive regulation of rhodopsin gene expression(GO:0045872) |
| 0.0 | 0.3 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
| 0.0 | 0.1 | GO:0032091 | negative regulation of protein binding(GO:0032091) |
| 0.0 | 0.0 | GO:0061371 | determination of heart left/right asymmetry(GO:0061371) |
| 0.0 | 0.2 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
| 0.0 | 0.4 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
| 0.0 | 0.2 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) regulation of NADP metabolic process(GO:1902031) |
| 0.0 | 0.1 | GO:0002818 | intracellular defense response(GO:0002818) |
| 0.0 | 0.2 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
| 0.0 | 0.3 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
| 0.0 | 1.1 | GO:0002244 | hematopoietic progenitor cell differentiation(GO:0002244) |
| 0.0 | 0.3 | GO:0006574 | valine catabolic process(GO:0006574) |
| 0.0 | 0.4 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
| 0.0 | 1.0 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.0 | 0.6 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
| 0.0 | 2.1 | GO:0019228 | neuronal action potential(GO:0019228) |
| 0.0 | 0.2 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
| 0.0 | 0.2 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
| 0.0 | 1.6 | GO:0016579 | protein deubiquitination(GO:0016579) |
| 0.0 | 0.3 | GO:0019050 | suppression by virus of host apoptotic process(GO:0019050) modulation by virus of host apoptotic process(GO:0039526) |
| 0.0 | 0.2 | GO:0048749 | compound eye development(GO:0048749) |
| 0.0 | 0.5 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
| 0.0 | 0.7 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
| 0.0 | 0.3 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
| 0.0 | 0.6 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
| 0.0 | 0.2 | GO:0071503 | response to heparin(GO:0071503) |
| 0.0 | 0.5 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
| 0.0 | 0.9 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
| 0.0 | 0.1 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
| 0.0 | 0.2 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
| 0.0 | 0.2 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
| 0.0 | 0.8 | GO:0071377 | response to glucagon(GO:0033762) cellular response to glucagon stimulus(GO:0071377) |
| 0.0 | 0.4 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
| 0.0 | 0.4 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
| 0.0 | 2.8 | GO:0050909 | sensory perception of taste(GO:0050909) |
| 0.0 | 0.3 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
| 0.0 | 0.1 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
| 0.0 | 0.4 | GO:0060368 | regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060368) |
| 0.0 | 0.8 | GO:0051023 | regulation of immunoglobulin secretion(GO:0051023) |
| 0.0 | 0.2 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
| 0.0 | 0.7 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
| 0.0 | 1.9 | GO:0006284 | base-excision repair(GO:0006284) |
| 0.0 | 0.3 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
| 0.0 | 0.1 | GO:1903027 | regulation of opsonization(GO:1903027) positive regulation of opsonization(GO:1903028) |
| 0.0 | 0.3 | GO:0097056 | selenocysteinyl-tRNA(Sec) biosynthetic process(GO:0097056) |
| 0.0 | 0.2 | GO:0042417 | dopamine metabolic process(GO:0042417) |
| 0.0 | 0.4 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.0 | 0.3 | GO:0044211 | CTP salvage(GO:0044211) |
| 0.0 | 0.2 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
| 0.0 | 0.5 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
| 0.0 | 0.1 | GO:1905044 | Schwann cell proliferation involved in axon regeneration(GO:0014011) negative regulation of Schwann cell migration(GO:1900148) regulation of Schwann cell proliferation involved in axon regeneration(GO:1905044) negative regulation of Schwann cell proliferation involved in axon regeneration(GO:1905045) |
| 0.0 | 2.0 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
| 0.0 | 0.3 | GO:0032411 | positive regulation of transporter activity(GO:0032411) |
| 0.0 | 0.2 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
| 0.0 | 0.2 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.0 | 0.1 | GO:0034086 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
| 0.0 | 0.1 | GO:0006338 | chromatin remodeling(GO:0006338) |
| 0.0 | 0.1 | GO:0051257 | meiotic metaphase I plate congression(GO:0043060) meiotic spindle midzone assembly(GO:0051257) meiotic metaphase plate congression(GO:0051311) |
| 0.0 | 0.1 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
| 0.0 | 1.6 | GO:0006379 | mRNA cleavage(GO:0006379) |
| 0.0 | 0.3 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
| 0.0 | 0.1 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
| 0.0 | 0.5 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
| 0.0 | 0.2 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
| 0.0 | 0.7 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
| 0.0 | 0.5 | GO:0035608 | protein deglutamylation(GO:0035608) |
| 0.0 | 0.2 | GO:0090166 | histone H3-S10 phosphorylation(GO:0043987) Golgi disassembly(GO:0090166) |
| 0.0 | 0.3 | GO:0032364 | oxygen homeostasis(GO:0032364) |
| 0.0 | 1.8 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) |
| 0.0 | 0.2 | GO:0061364 | apoptotic process involved in luteolysis(GO:0061364) |
| 0.0 | 0.2 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
| 0.0 | 1.9 | GO:0006968 | cellular defense response(GO:0006968) |
| 0.0 | 0.2 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
| 0.0 | 0.7 | GO:0016024 | CDP-diacylglycerol biosynthetic process(GO:0016024) |
| 0.0 | 0.4 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
| 0.0 | 0.1 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
| 0.0 | 0.7 | GO:0009437 | carnitine metabolic process(GO:0009437) |
| 0.0 | 0.6 | GO:0051601 | exocyst localization(GO:0051601) |
| 0.0 | 0.4 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
| 0.0 | 1.4 | GO:0045840 | positive regulation of mitotic nuclear division(GO:0045840) |
| 0.0 | 0.9 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
| 0.0 | 0.2 | GO:0009409 | response to cold(GO:0009409) |
| 0.0 | 0.2 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.0 | 0.5 | GO:0038203 | TORC2 signaling(GO:0038203) |
| 0.0 | 0.7 | GO:0034605 | cellular response to heat(GO:0034605) |
| 0.0 | 0.3 | GO:0043149 | contractile actin filament bundle assembly(GO:0030038) stress fiber assembly(GO:0043149) |
| 0.0 | 0.3 | GO:0071371 | cellular response to gonadotropin stimulus(GO:0071371) |
| 0.0 | 0.3 | GO:1903817 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
| 0.0 | 0.0 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
| 0.0 | 0.4 | GO:0043249 | erythrocyte maturation(GO:0043249) |
| 0.0 | 0.6 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
| 0.0 | 0.6 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
| 0.0 | 0.1 | GO:0051106 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
| 0.0 | 0.6 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
| 0.0 | 0.2 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
| 0.0 | 1.1 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
| 0.0 | 0.6 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.0 | 0.1 | GO:1904970 | brush border assembly(GO:1904970) |
| 0.0 | 0.5 | GO:0008595 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
| 0.0 | 0.2 | GO:0070560 | protein secretion by platelet(GO:0070560) |
| 0.0 | 0.7 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
| 0.0 | 1.0 | GO:0097120 | receptor localization to synapse(GO:0097120) |
| 0.0 | 0.2 | GO:0048302 | isotype switching to IgG isotypes(GO:0048291) regulation of isotype switching to IgG isotypes(GO:0048302) |
| 0.0 | 0.1 | GO:0007056 | spindle assembly involved in female meiosis(GO:0007056) |
| 0.0 | 0.1 | GO:0002860 | positive regulation of response to tumor cell(GO:0002836) positive regulation of immune response to tumor cell(GO:0002839) positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
| 0.0 | 0.4 | GO:0099639 | neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) neurotransmitter receptor transport, endosome to plasma membrane(GO:0099639) |
| 0.0 | 0.5 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
| 0.0 | 0.5 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.0 | 0.1 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 0.0 | 0.1 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
| 0.0 | 0.2 | GO:0035799 | ureter maturation(GO:0035799) |
| 0.0 | 1.1 | GO:0009214 | cyclic nucleotide catabolic process(GO:0009214) |
| 0.0 | 1.4 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
| 0.0 | 2.4 | GO:0060563 | neuroepithelial cell differentiation(GO:0060563) |
| 0.0 | 0.1 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
| 0.0 | 0.1 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
| 0.0 | 0.4 | GO:0043486 | histone exchange(GO:0043486) |
| 0.0 | 0.2 | GO:0003418 | growth plate cartilage chondrocyte differentiation(GO:0003418) |
| 0.0 | 0.2 | GO:0043129 | surfactant homeostasis(GO:0043129) |
| 0.0 | 0.4 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
| 0.0 | 0.1 | GO:0009386 | translational attenuation(GO:0009386) |
| 0.0 | 0.3 | GO:0016925 | protein sumoylation(GO:0016925) |
| 0.0 | 0.2 | GO:1901977 | negative regulation of cell cycle checkpoint(GO:1901977) negative regulation of DNA damage checkpoint(GO:2000002) |
| 0.0 | 0.4 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
| 0.0 | 0.7 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
| 0.0 | 0.6 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
| 0.0 | 0.3 | GO:2000615 | regulation of histone H3-K9 acetylation(GO:2000615) |
| 0.0 | 0.0 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
| 0.0 | 0.2 | GO:0030534 | adult behavior(GO:0030534) |
| 0.0 | 0.4 | GO:0010663 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
| 0.0 | 0.1 | GO:0043248 | proteasome assembly(GO:0043248) |
| 0.0 | 0.2 | GO:0034104 | negative regulation of tissue remodeling(GO:0034104) |
| 0.0 | 0.2 | GO:0071492 | cellular response to UV-A(GO:0071492) |
| 0.0 | 0.9 | GO:0005980 | glycogen catabolic process(GO:0005980) |
| 0.0 | 0.1 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) |
| 0.0 | 0.4 | GO:0070208 | protein heterotrimerization(GO:0070208) |
| 0.0 | 0.4 | GO:0007567 | parturition(GO:0007567) |
| 0.0 | 0.3 | GO:0034724 | DNA replication-independent nucleosome organization(GO:0034724) |
| 0.0 | 0.0 | GO:0046666 | retinal cell programmed cell death(GO:0046666) |
| 0.0 | 0.1 | GO:0021764 | amygdala development(GO:0021764) |
| 0.0 | 0.2 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
| 0.0 | 0.3 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
| 0.0 | 0.1 | GO:0033274 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 0.0 | 0.2 | GO:0032264 | IMP salvage(GO:0032264) |
| 0.0 | 0.2 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
| 0.0 | 0.2 | GO:0043383 | negative T cell selection(GO:0043383) |
| 0.0 | 0.4 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.0 | 0.2 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 0.0 | 0.4 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
| 0.0 | 1.2 | GO:0071347 | cellular response to interleukin-1(GO:0071347) |
| 0.0 | 1.0 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
| 0.0 | 0.2 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
| 0.0 | 0.3 | GO:0006271 | DNA strand elongation involved in DNA replication(GO:0006271) |
| 0.0 | 0.3 | GO:0032098 | regulation of appetite(GO:0032098) |
| 0.0 | 0.4 | GO:0002433 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis(GO:0002433) Fc-gamma receptor signaling pathway involved in phagocytosis(GO:0038096) |
| 0.0 | 0.6 | GO:0030207 | chondroitin sulfate catabolic process(GO:0030207) |
| 0.0 | 1.5 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
| 0.0 | 0.2 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
| 0.0 | 2.2 | GO:1903955 | positive regulation of protein targeting to mitochondrion(GO:1903955) |
| 0.0 | 0.2 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.0 | 0.5 | GO:0043968 | histone H2A acetylation(GO:0043968) |
| 0.0 | 0.1 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
| 0.0 | 0.1 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
| 0.0 | 0.8 | GO:0042407 | cristae formation(GO:0042407) |
| 0.0 | 0.1 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
| 0.0 | 1.9 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
| 0.0 | 0.1 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
| 0.0 | 0.6 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
| 0.0 | 0.5 | GO:0030325 | adrenal gland development(GO:0030325) |
| 0.0 | 0.4 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
| 0.0 | 0.2 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 0.0 | 0.1 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
| 0.0 | 0.1 | GO:0021702 | cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
| 0.0 | 0.3 | GO:0006024 | glycosaminoglycan biosynthetic process(GO:0006024) |
| 0.0 | 1.3 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
| 0.0 | 0.3 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
| 0.0 | 0.7 | GO:0015701 | bicarbonate transport(GO:0015701) |
| 0.0 | 0.2 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
| 0.0 | 0.2 | GO:0071420 | cellular response to histamine(GO:0071420) |
| 0.0 | 0.0 | GO:0019046 | release from viral latency(GO:0019046) |
| 0.0 | 0.2 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
| 0.0 | 0.4 | GO:0018126 | protein hydroxylation(GO:0018126) |
| 0.0 | 0.6 | GO:0051703 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
| 0.0 | 0.0 | GO:0038155 | interleukin-23-mediated signaling pathway(GO:0038155) positive regulation of T-helper 17 cell lineage commitment(GO:2000330) |
| 0.0 | 0.2 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
| 0.0 | 0.1 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
| 0.0 | 0.7 | GO:0042572 | retinol metabolic process(GO:0042572) |
| 0.0 | 0.2 | GO:1903963 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
| 0.0 | 0.1 | GO:0003096 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
| 0.0 | 0.1 | GO:0030432 | peristalsis(GO:0030432) |
| 0.0 | 0.2 | GO:0071361 | cellular response to ethanol(GO:0071361) |
| 0.0 | 0.1 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
| 0.0 | 0.7 | GO:0035036 | sperm-egg recognition(GO:0035036) |
| 0.0 | 0.0 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
| 0.0 | 0.1 | GO:0042711 | maternal behavior(GO:0042711) parental behavior(GO:0060746) |
| 0.0 | 0.3 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
| 0.0 | 0.1 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.0 | 0.1 | GO:0060174 | limb bud formation(GO:0060174) |
| 0.0 | 0.4 | GO:0050766 | positive regulation of phagocytosis(GO:0050766) |
| 0.0 | 0.1 | GO:0045716 | positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
| 0.0 | 0.1 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
| 0.0 | 0.1 | GO:0032228 | regulation of synaptic transmission, GABAergic(GO:0032228) |
| 0.0 | 0.2 | GO:1903504 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
| 0.0 | 0.1 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) |
| 0.0 | 0.2 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
| 0.0 | 0.7 | GO:0007632 | visual behavior(GO:0007632) |
| 0.0 | 0.1 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 0.0 | 0.3 | GO:0007588 | excretion(GO:0007588) |
| 0.0 | 0.2 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
| 0.0 | 0.2 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 0.0 | 0.2 | GO:0007224 | smoothened signaling pathway(GO:0007224) |
| 0.0 | 0.1 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
| 0.0 | 0.1 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
| 0.0 | 0.0 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
| 0.0 | 0.1 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.0 | 0.2 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
| 0.0 | 0.0 | GO:0002372 | myeloid dendritic cell cytokine production(GO:0002372) |
| 0.0 | 0.3 | GO:0070301 | cellular response to hydrogen peroxide(GO:0070301) |
| 0.0 | 0.2 | GO:1902307 | positive regulation of sodium ion transmembrane transport(GO:1902307) positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
| 0.0 | 0.2 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
| 0.0 | 0.1 | GO:0015671 | oxygen transport(GO:0015671) |
| 0.0 | 0.2 | GO:0048665 | neuron fate specification(GO:0048665) |
| 0.0 | 0.2 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
| 0.0 | 0.0 | GO:0070231 | T cell apoptotic process(GO:0070231) regulation of T cell apoptotic process(GO:0070232) |
| 0.0 | 0.1 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.9 | 3.5 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
| 0.8 | 7.8 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) synaptobrevin 2-SNAP-25-syntaxin-3-complexin complex(GO:0070554) |
| 0.6 | 15.5 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
| 0.5 | 2.5 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) CNTFR-CLCF1 complex(GO:0097059) |
| 0.5 | 2.0 | GO:0071062 | rough endoplasmic reticulum lumen(GO:0048237) alphav-beta3 integrin-vitronectin complex(GO:0071062) |
| 0.4 | 3.1 | GO:0043196 | varicosity(GO:0043196) |
| 0.4 | 3.1 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
| 0.4 | 6.5 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
| 0.3 | 1.2 | GO:0044753 | amphisome(GO:0044753) |
| 0.3 | 0.9 | GO:0005668 | RNA polymerase transcription factor SL1 complex(GO:0005668) |
| 0.3 | 2.3 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
| 0.3 | 2.5 | GO:0035976 | AP1 complex(GO:0035976) |
| 0.3 | 4.6 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
| 0.3 | 1.0 | GO:0008043 | intracellular ferritin complex(GO:0008043) ferritin complex(GO:0070288) |
| 0.2 | 1.0 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
| 0.2 | 0.7 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
| 0.2 | 5.5 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
| 0.2 | 4.7 | GO:0036038 | MKS complex(GO:0036038) |
| 0.2 | 0.8 | GO:0035354 | Toll-like receptor 1-Toll-like receptor 2 protein complex(GO:0035354) |
| 0.2 | 5.7 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
| 0.2 | 0.6 | GO:0035101 | FACT complex(GO:0035101) |
| 0.2 | 3.3 | GO:0033093 | Weibel-Palade body(GO:0033093) |
| 0.2 | 1.6 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
| 0.2 | 1.1 | GO:1990246 | uniplex complex(GO:1990246) |
| 0.2 | 2.1 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
| 0.2 | 2.2 | GO:0042788 | polysomal ribosome(GO:0042788) |
| 0.2 | 1.0 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
| 0.2 | 12.7 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
| 0.2 | 2.9 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
| 0.1 | 0.6 | GO:0097196 | Shu complex(GO:0097196) |
| 0.1 | 1.7 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
| 0.1 | 1.4 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
| 0.1 | 0.6 | GO:0042585 | germinal vesicle(GO:0042585) |
| 0.1 | 0.7 | GO:0070701 | mucus layer(GO:0070701) |
| 0.1 | 1.7 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
| 0.1 | 10.2 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
| 0.1 | 0.7 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
| 0.1 | 0.5 | GO:0019815 | B cell receptor complex(GO:0019815) |
| 0.1 | 0.9 | GO:1990812 | growth cone filopodium(GO:1990812) |
| 0.1 | 0.6 | GO:0002133 | polycystin complex(GO:0002133) |
| 0.1 | 0.5 | GO:0000126 | transcription factor TFIIIB complex(GO:0000126) |
| 0.1 | 0.4 | GO:0002947 | tumor necrosis factor receptor superfamily complex(GO:0002947) |
| 0.1 | 2.4 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
| 0.1 | 0.9 | GO:0061617 | MICOS complex(GO:0061617) |
| 0.1 | 0.5 | GO:1990423 | RZZ complex(GO:1990423) |
| 0.1 | 1.3 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
| 0.1 | 0.8 | GO:0033565 | ESCRT-0 complex(GO:0033565) |
| 0.1 | 0.6 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
| 0.1 | 0.8 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
| 0.1 | 2.2 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
| 0.1 | 0.3 | GO:0005588 | collagen type V trimer(GO:0005588) |
| 0.1 | 1.0 | GO:0005638 | lamin filament(GO:0005638) |
| 0.1 | 0.5 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
| 0.1 | 1.0 | GO:0031931 | TORC1 complex(GO:0031931) |
| 0.1 | 0.7 | GO:0016272 | prefoldin complex(GO:0016272) |
| 0.1 | 0.4 | GO:0034684 | integrin alphav-beta5 complex(GO:0034684) |
| 0.1 | 2.2 | GO:0030667 | secretory granule membrane(GO:0030667) |
| 0.1 | 6.9 | GO:0005844 | polysome(GO:0005844) |
| 0.1 | 0.6 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
| 0.1 | 0.7 | GO:0005899 | insulin receptor complex(GO:0005899) |
| 0.1 | 1.0 | GO:0016589 | NURF complex(GO:0016589) |
| 0.1 | 1.7 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
| 0.1 | 3.6 | GO:0043218 | compact myelin(GO:0043218) |
| 0.1 | 4.0 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
| 0.1 | 2.9 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
| 0.1 | 0.9 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
| 0.1 | 0.3 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
| 0.1 | 10.3 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
| 0.1 | 1.0 | GO:0032009 | early phagosome(GO:0032009) |
| 0.1 | 0.6 | GO:0044305 | calyx of Held(GO:0044305) |
| 0.1 | 6.3 | GO:0005747 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
| 0.1 | 0.3 | GO:0000811 | GINS complex(GO:0000811) |
| 0.1 | 1.7 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
| 0.1 | 0.3 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
| 0.1 | 0.7 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
| 0.1 | 2.9 | GO:0031231 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
| 0.1 | 0.2 | GO:0005608 | laminin-3 complex(GO:0005608) |
| 0.1 | 1.8 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
| 0.1 | 1.1 | GO:0035631 | CD40 receptor complex(GO:0035631) |
| 0.1 | 0.6 | GO:0005579 | membrane attack complex(GO:0005579) |
| 0.1 | 1.3 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
| 0.1 | 3.1 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
| 0.1 | 1.7 | GO:0032591 | dendritic spine membrane(GO:0032591) |
| 0.1 | 6.3 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
| 0.1 | 1.1 | GO:0005818 | astral microtubule(GO:0000235) aster(GO:0005818) |
| 0.1 | 1.7 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
| 0.1 | 0.5 | GO:0060201 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
| 0.1 | 0.8 | GO:0031616 | spindle pole centrosome(GO:0031616) |
| 0.1 | 0.4 | GO:0098837 | postsynaptic recycling endosome(GO:0098837) |
| 0.1 | 1.0 | GO:0019774 | proteasome core complex, beta-subunit complex(GO:0019774) |
| 0.1 | 0.4 | GO:0005594 | collagen type IX trimer(GO:0005594) |
| 0.1 | 0.4 | GO:0005833 | hemoglobin complex(GO:0005833) |
| 0.1 | 0.5 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
| 0.1 | 0.5 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
| 0.1 | 10.0 | GO:0043202 | lysosomal lumen(GO:0043202) |
| 0.1 | 1.9 | GO:0005685 | U1 snRNP(GO:0005685) |
| 0.1 | 0.7 | GO:0005883 | neurofilament(GO:0005883) |
| 0.1 | 1.6 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
| 0.0 | 0.6 | GO:0000796 | condensin complex(GO:0000796) |
| 0.0 | 0.3 | GO:1990131 | Gtr1-Gtr2 GTPase complex(GO:1990131) |
| 0.0 | 0.3 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
| 0.0 | 0.4 | GO:0070821 | tertiary granule membrane(GO:0070821) |
| 0.0 | 0.3 | GO:1990357 | terminal web(GO:1990357) |
| 0.0 | 0.1 | GO:0097013 | phagocytic vesicle lumen(GO:0097013) |
| 0.0 | 0.4 | GO:0034688 | integrin alphaM-beta2 complex(GO:0034688) |
| 0.0 | 0.4 | GO:0001740 | Barr body(GO:0001740) |
| 0.0 | 0.3 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
| 0.0 | 0.8 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
| 0.0 | 0.9 | GO:0042613 | MHC class II protein complex(GO:0042613) |
| 0.0 | 1.9 | GO:0030673 | axolemma(GO:0030673) |
| 0.0 | 0.6 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
| 0.0 | 1.6 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
| 0.0 | 1.0 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
| 0.0 | 0.6 | GO:0070652 | HAUS complex(GO:0070652) |
| 0.0 | 0.2 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
| 0.0 | 2.8 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
| 0.0 | 0.3 | GO:0097361 | CIA complex(GO:0097361) |
| 0.0 | 0.7 | GO:0000815 | ESCRT III complex(GO:0000815) |
| 0.0 | 1.1 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
| 0.0 | 3.8 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
| 0.0 | 0.6 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
| 0.0 | 0.2 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
| 0.0 | 1.3 | GO:0034451 | centriolar satellite(GO:0034451) |
| 0.0 | 0.4 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
| 0.0 | 0.3 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
| 0.0 | 0.4 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
| 0.0 | 0.1 | GO:0005715 | late recombination nodule(GO:0005715) |
| 0.0 | 0.1 | GO:0044393 | microspike(GO:0044393) |
| 0.0 | 2.7 | GO:0035580 | specific granule lumen(GO:0035580) |
| 0.0 | 1.3 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
| 0.0 | 0.4 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
| 0.0 | 0.7 | GO:0000812 | Swr1 complex(GO:0000812) |
| 0.0 | 0.6 | GO:0030008 | TRAPP complex(GO:0030008) |
| 0.0 | 5.1 | GO:0072562 | blood microparticle(GO:0072562) |
| 0.0 | 1.4 | GO:0000421 | autophagosome membrane(GO:0000421) |
| 0.0 | 0.7 | GO:0097542 | ciliary tip(GO:0097542) |
| 0.0 | 1.9 | GO:0032420 | stereocilium(GO:0032420) |
| 0.0 | 4.6 | GO:0030666 | endocytic vesicle membrane(GO:0030666) |
| 0.0 | 0.5 | GO:0005915 | zonula adherens(GO:0005915) |
| 0.0 | 0.2 | GO:0005686 | U2 snRNP(GO:0005686) |
| 0.0 | 0.9 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
| 0.0 | 0.2 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
| 0.0 | 0.1 | GO:0032421 | stereocilium bundle(GO:0032421) |
| 0.0 | 0.4 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
| 0.0 | 2.7 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
| 0.0 | 0.5 | GO:0038201 | TORC2 complex(GO:0031932) TOR complex(GO:0038201) |
| 0.0 | 1.9 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
| 0.0 | 1.6 | GO:0016235 | aggresome(GO:0016235) |
| 0.0 | 0.7 | GO:0005684 | U2-type spliceosomal complex(GO:0005684) |
| 0.0 | 2.2 | GO:0005905 | clathrin-coated pit(GO:0005905) |
| 0.0 | 0.1 | GO:0031523 | Myb complex(GO:0031523) |
| 0.0 | 1.6 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
| 0.0 | 0.3 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
| 0.0 | 37.4 | GO:0005615 | extracellular space(GO:0005615) |
| 0.0 | 0.2 | GO:0097512 | cardiac myofibril(GO:0097512) |
| 0.0 | 0.2 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
| 0.0 | 1.4 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
| 0.0 | 0.2 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
| 0.0 | 0.2 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
| 0.0 | 0.2 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) |
| 0.0 | 0.3 | GO:0045120 | pronucleus(GO:0045120) |
| 0.0 | 0.1 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
| 0.0 | 0.6 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
| 0.0 | 0.6 | GO:0005859 | muscle myosin complex(GO:0005859) |
| 0.0 | 0.7 | GO:0000145 | exocyst(GO:0000145) |
| 0.0 | 3.8 | GO:0031301 | integral component of organelle membrane(GO:0031301) |
| 0.0 | 0.1 | GO:0031085 | BLOC-3 complex(GO:0031085) |
| 0.0 | 0.3 | GO:0070187 | telosome(GO:0070187) |
| 0.0 | 1.1 | GO:0034707 | chloride channel complex(GO:0034707) |
| 0.0 | 1.5 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
| 0.0 | 0.2 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
| 0.0 | 0.3 | GO:0042101 | T cell receptor complex(GO:0042101) |
| 0.0 | 0.2 | GO:0030663 | COPI vesicle coat(GO:0030126) COPI-coated vesicle membrane(GO:0030663) |
| 0.0 | 0.8 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
| 0.0 | 0.1 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
| 0.0 | 0.2 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
| 0.0 | 0.2 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
| 0.0 | 0.3 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
| 0.0 | 0.3 | GO:0010369 | chromocenter(GO:0010369) |
| 0.0 | 0.0 | GO:0042022 | interleukin-12 receptor complex(GO:0042022) |
| 0.0 | 1.5 | GO:0035579 | specific granule membrane(GO:0035579) |
| 0.0 | 0.2 | GO:0031904 | endosome lumen(GO:0031904) |
| 0.0 | 0.2 | GO:0033391 | chromatoid body(GO:0033391) |
| 0.0 | 0.1 | GO:1902912 | pyruvate kinase complex(GO:1902912) |
| 0.0 | 0.4 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
| 0.0 | 0.0 | GO:0051286 | cell tip(GO:0051286) |
| 0.0 | 0.1 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
| 0.0 | 0.5 | GO:0005921 | gap junction(GO:0005921) |
| 0.0 | 0.2 | GO:0005682 | U5 snRNP(GO:0005682) |
| 0.0 | 0.1 | GO:0072687 | meiotic spindle(GO:0072687) |
| 0.0 | 0.1 | GO:0045261 | proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.2 | 6.5 | GO:0016603 | glutaminyl-peptide cyclotransferase activity(GO:0016603) |
| 1.6 | 8.2 | GO:0003947 | (N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity(GO:0003947) |
| 1.4 | 8.4 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
| 1.3 | 3.8 | GO:0019862 | IgA binding(GO:0019862) |
| 1.1 | 4.3 | GO:0047708 | biotinidase activity(GO:0047708) |
| 1.0 | 7.2 | GO:0008955 | peptidoglycan glycosyltransferase activity(GO:0008955) |
| 1.0 | 3.0 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
| 0.9 | 16.7 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
| 0.8 | 2.3 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
| 0.7 | 15.5 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
| 0.7 | 2.2 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
| 0.6 | 3.7 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
| 0.6 | 1.8 | GO:0004020 | adenylylsulfate kinase activity(GO:0004020) sulfate adenylyltransferase activity(GO:0004779) sulfate adenylyltransferase (ATP) activity(GO:0004781) |
| 0.6 | 1.8 | GO:0036361 | racemase and epimerase activity, acting on amino acids and derivatives(GO:0016855) racemase activity, acting on amino acids and derivatives(GO:0036361) amino-acid racemase activity(GO:0047661) |
| 0.6 | 2.3 | GO:0004356 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) acid-ammonia (or amide) ligase activity(GO:0016880) |
| 0.5 | 4.4 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
| 0.5 | 2.4 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
| 0.5 | 1.9 | GO:0030760 | nicotinamide N-methyltransferase activity(GO:0008112) pyridine N-methyltransferase activity(GO:0030760) |
| 0.5 | 1.9 | GO:0047860 | diiodophenylpyruvate reductase activity(GO:0047860) |
| 0.5 | 1.4 | GO:0031896 | V2 vasopressin receptor binding(GO:0031896) |
| 0.4 | 2.2 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
| 0.4 | 1.2 | GO:1904713 | beta-catenin destruction complex binding(GO:1904713) |
| 0.4 | 2.0 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
| 0.4 | 2.0 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
| 0.4 | 11.6 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
| 0.4 | 1.1 | GO:0047225 | acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0047225) |
| 0.4 | 4.8 | GO:1901612 | cardiolipin binding(GO:1901612) |
| 0.4 | 3.9 | GO:0032190 | acrosin binding(GO:0032190) |
| 0.4 | 3.2 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
| 0.3 | 4.1 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
| 0.3 | 1.3 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
| 0.3 | 0.9 | GO:0005174 | CD40 receptor binding(GO:0005174) |
| 0.3 | 1.8 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
| 0.3 | 0.9 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) DNA/RNA helicase activity(GO:0033677) |
| 0.3 | 2.9 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
| 0.3 | 2.0 | GO:0000405 | bubble DNA binding(GO:0000405) |
| 0.3 | 1.1 | GO:0051733 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
| 0.3 | 1.4 | GO:0008466 | glycogenin glucosyltransferase activity(GO:0008466) |
| 0.3 | 6.5 | GO:0050786 | RAGE receptor binding(GO:0050786) |
| 0.3 | 2.2 | GO:0008523 | sodium-dependent multivitamin transmembrane transporter activity(GO:0008523) |
| 0.3 | 0.8 | GO:0044549 | GTP cyclohydrolase binding(GO:0044549) |
| 0.3 | 0.8 | GO:0031691 | alpha-1A adrenergic receptor binding(GO:0031691) follicle-stimulating hormone receptor binding(GO:0031762) platelet activating factor receptor binding(GO:0031859) |
| 0.3 | 11.5 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
| 0.3 | 2.7 | GO:0051378 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
| 0.3 | 1.5 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
| 0.3 | 5.7 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
| 0.2 | 1.0 | GO:0004113 | 2',3'-cyclic-nucleotide 3'-phosphodiesterase activity(GO:0004113) |
| 0.2 | 0.7 | GO:0047726 | iron-cytochrome-c reductase activity(GO:0047726) |
| 0.2 | 0.7 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
| 0.2 | 7.8 | GO:0051787 | misfolded protein binding(GO:0051787) |
| 0.2 | 1.1 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
| 0.2 | 1.1 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
| 0.2 | 0.6 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) 8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity(GO:0035539) |
| 0.2 | 0.4 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
| 0.2 | 0.8 | GO:0015403 | thiamine uptake transmembrane transporter activity(GO:0015403) |
| 0.2 | 0.8 | GO:0004967 | glucagon receptor activity(GO:0004967) |
| 0.2 | 1.4 | GO:0004522 | ribonuclease A activity(GO:0004522) |
| 0.2 | 1.6 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
| 0.2 | 0.2 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
| 0.2 | 1.0 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
| 0.2 | 0.6 | GO:1904928 | coreceptor activity involved in canonical Wnt signaling pathway(GO:1904928) |
| 0.2 | 0.9 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
| 0.2 | 0.6 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
| 0.2 | 0.7 | GO:0032408 | MutLbeta complex binding(GO:0032406) MutSbeta complex binding(GO:0032408) |
| 0.2 | 1.8 | GO:1990446 | U1 snRNP binding(GO:1990446) |
| 0.2 | 0.9 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
| 0.2 | 2.0 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
| 0.2 | 1.5 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
| 0.2 | 0.8 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
| 0.2 | 1.0 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
| 0.2 | 1.1 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
| 0.2 | 2.2 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 0.2 | 1.2 | GO:0052795 | exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
| 0.2 | 0.6 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
| 0.2 | 0.6 | GO:0097363 | protein O-GlcNAc transferase activity(GO:0097363) |
| 0.2 | 0.8 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
| 0.2 | 0.5 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
| 0.1 | 8.0 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
| 0.1 | 0.4 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
| 0.1 | 2.5 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
| 0.1 | 1.7 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
| 0.1 | 2.7 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
| 0.1 | 0.6 | GO:0004803 | transposase activity(GO:0004803) |
| 0.1 | 0.7 | GO:0033695 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
| 0.1 | 2.2 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
| 0.1 | 0.9 | GO:0016403 | dimethylargininase activity(GO:0016403) |
| 0.1 | 1.4 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
| 0.1 | 2.6 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
| 0.1 | 0.6 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
| 0.1 | 0.5 | GO:0001026 | TFIIIB-type transcription factor activity(GO:0001026) |
| 0.1 | 0.2 | GO:0019863 | IgE binding(GO:0019863) |
| 0.1 | 4.6 | GO:0001848 | complement binding(GO:0001848) |
| 0.1 | 0.4 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
| 0.1 | 0.6 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
| 0.1 | 0.8 | GO:0097199 | cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097199) |
| 0.1 | 0.6 | GO:0030197 | extracellular matrix constituent, lubricant activity(GO:0030197) |
| 0.1 | 0.3 | GO:0015439 | heme-transporting ATPase activity(GO:0015439) |
| 0.1 | 0.9 | GO:0050682 | AF-2 domain binding(GO:0050682) |
| 0.1 | 1.4 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
| 0.1 | 1.3 | GO:0003796 | lysozyme activity(GO:0003796) |
| 0.1 | 0.3 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
| 0.1 | 1.4 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
| 0.1 | 0.3 | GO:1990699 | palmitoleyl hydrolase activity(GO:1990699) |
| 0.1 | 6.6 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
| 0.1 | 1.6 | GO:0015232 | heme transporter activity(GO:0015232) |
| 0.1 | 1.0 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
| 0.1 | 0.3 | GO:1904599 | advanced glycation end-product binding(GO:1904599) |
| 0.1 | 0.7 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
| 0.1 | 0.9 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
| 0.1 | 1.3 | GO:0051525 | NFAT protein binding(GO:0051525) |
| 0.1 | 3.1 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
| 0.1 | 0.6 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
| 0.1 | 0.4 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
| 0.1 | 2.4 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
| 0.1 | 2.0 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
| 0.1 | 0.9 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
| 0.1 | 2.1 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
| 0.1 | 1.0 | GO:0019237 | centromeric DNA binding(GO:0019237) |
| 0.1 | 2.7 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
| 0.1 | 0.3 | GO:0001596 | angiotensin type I receptor activity(GO:0001596) |
| 0.1 | 0.7 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
| 0.1 | 0.3 | GO:0097689 | iron channel activity(GO:0097689) |
| 0.1 | 1.2 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
| 0.1 | 0.4 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
| 0.1 | 2.1 | GO:0000217 | DNA secondary structure binding(GO:0000217) |
| 0.1 | 0.5 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
| 0.1 | 3.6 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
| 0.1 | 1.6 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
| 0.1 | 0.7 | GO:0035174 | histone serine kinase activity(GO:0035174) |
| 0.1 | 0.4 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
| 0.1 | 0.5 | GO:0051373 | FATZ binding(GO:0051373) |
| 0.1 | 0.7 | GO:0031779 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
| 0.1 | 0.9 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
| 0.1 | 0.2 | GO:0019808 | polyamine binding(GO:0019808) |
| 0.1 | 0.7 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
| 0.1 | 0.9 | GO:0004904 | interferon receptor activity(GO:0004904) |
| 0.1 | 1.1 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
| 0.1 | 0.3 | GO:0004088 | carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) |
| 0.1 | 0.5 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
| 0.1 | 1.0 | GO:0031419 | cobalamin binding(GO:0031419) |
| 0.1 | 2.3 | GO:0050699 | WW domain binding(GO:0050699) |
| 0.1 | 2.4 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
| 0.1 | 5.3 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
| 0.1 | 0.2 | GO:0004925 | prolactin receptor activity(GO:0004925) |
| 0.1 | 2.1 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
| 0.1 | 0.7 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
| 0.1 | 0.8 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
| 0.1 | 0.3 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
| 0.1 | 0.5 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
| 0.1 | 0.5 | GO:0004515 | nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
| 0.1 | 0.3 | GO:0048030 | disaccharide binding(GO:0048030) |
| 0.1 | 1.3 | GO:0008527 | taste receptor activity(GO:0008527) |
| 0.1 | 0.2 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
| 0.1 | 0.4 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
| 0.1 | 2.6 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
| 0.1 | 0.3 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
| 0.1 | 0.4 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
| 0.1 | 2.0 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 0.1 | 3.0 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
| 0.1 | 5.7 | GO:0050840 | extracellular matrix binding(GO:0050840) |
| 0.1 | 0.3 | GO:0001884 | pyrimidine nucleoside binding(GO:0001884) UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) |
| 0.1 | 1.8 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
| 0.1 | 0.3 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
| 0.1 | 0.2 | GO:0016936 | galactoside binding(GO:0016936) |
| 0.1 | 0.9 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
| 0.1 | 0.4 | GO:0047820 | D-glutamate cyclase activity(GO:0047820) |
| 0.1 | 2.8 | GO:0051059 | NF-kappaB binding(GO:0051059) |
| 0.1 | 0.5 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
| 0.1 | 0.6 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
| 0.1 | 0.5 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
| 0.1 | 1.0 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
| 0.1 | 0.2 | GO:0086020 | gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling(GO:0086020) |
| 0.1 | 1.9 | GO:0042288 | MHC class I protein binding(GO:0042288) |
| 0.1 | 0.2 | GO:0005260 | channel-conductance-controlling ATPase activity(GO:0005260) |
| 0.1 | 0.3 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
| 0.1 | 0.2 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
| 0.1 | 3.4 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
| 0.1 | 0.6 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
| 0.1 | 0.3 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
| 0.1 | 0.9 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
| 0.1 | 0.3 | GO:0023024 | MHC class I protein complex binding(GO:0023024) |
| 0.1 | 1.8 | GO:0003746 | translation elongation factor activity(GO:0003746) |
| 0.1 | 0.2 | GO:0042007 | interleukin-18 binding(GO:0042007) |
| 0.1 | 0.3 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
| 0.1 | 0.2 | GO:0034039 | 8-oxo-7,8-dihydroguanine DNA N-glycosylase activity(GO:0034039) |
| 0.1 | 0.5 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
| 0.0 | 0.2 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
| 0.0 | 0.3 | GO:0050294 | steroid sulfotransferase activity(GO:0050294) |
| 0.0 | 1.1 | GO:0070628 | proteasome binding(GO:0070628) |
| 0.0 | 1.7 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
| 0.0 | 0.2 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
| 0.0 | 0.8 | GO:0015217 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
| 0.0 | 0.2 | GO:0004082 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
| 0.0 | 0.5 | GO:0004969 | histamine receptor activity(GO:0004969) |
| 0.0 | 0.5 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
| 0.0 | 0.3 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
| 0.0 | 0.2 | GO:0019770 | IgG receptor activity(GO:0019770) |
| 0.0 | 0.3 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
| 0.0 | 0.9 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
| 0.0 | 0.4 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
| 0.0 | 0.4 | GO:0030957 | Tat protein binding(GO:0030957) |
| 0.0 | 1.0 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
| 0.0 | 0.4 | GO:0004985 | opioid receptor activity(GO:0004985) |
| 0.0 | 0.1 | GO:0090541 | MIT domain binding(GO:0090541) |
| 0.0 | 0.3 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
| 0.0 | 0.3 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
| 0.0 | 0.3 | GO:0005497 | androgen binding(GO:0005497) |
| 0.0 | 0.2 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
| 0.0 | 0.3 | GO:0017018 | myosin phosphatase activity(GO:0017018) |
| 0.0 | 0.1 | GO:0045518 | interleukin-22 receptor binding(GO:0045518) |
| 0.0 | 0.2 | GO:0035473 | lipase binding(GO:0035473) |
| 0.0 | 0.3 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
| 0.0 | 0.2 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
| 0.0 | 0.5 | GO:0048156 | tau protein binding(GO:0048156) |
| 0.0 | 0.1 | GO:0004613 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
| 0.0 | 1.0 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
| 0.0 | 0.5 | GO:0032051 | clathrin light chain binding(GO:0032051) |
| 0.0 | 1.6 | GO:0048487 | beta-tubulin binding(GO:0048487) |
| 0.0 | 0.3 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
| 0.0 | 1.2 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
| 0.0 | 0.9 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
| 0.0 | 0.3 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
| 0.0 | 0.6 | GO:0017091 | AU-rich element binding(GO:0017091) |
| 0.0 | 0.2 | GO:0034711 | inhibin binding(GO:0034711) |
| 0.0 | 0.1 | GO:0005019 | platelet-derived growth factor beta-receptor activity(GO:0005019) |
| 0.0 | 0.4 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
| 0.0 | 0.7 | GO:0070513 | death domain binding(GO:0070513) |
| 0.0 | 1.0 | GO:0070182 | DNA polymerase binding(GO:0070182) |
| 0.0 | 2.9 | GO:0019843 | rRNA binding(GO:0019843) |
| 0.0 | 0.1 | GO:0032184 | SUMO polymer binding(GO:0032184) |
| 0.0 | 0.1 | GO:0050528 | acyloxyacyl hydrolase activity(GO:0050528) |
| 0.0 | 0.4 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
| 0.0 | 0.5 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
| 0.0 | 0.4 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
| 0.0 | 0.3 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
| 0.0 | 0.3 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
| 0.0 | 0.1 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
| 0.0 | 1.3 | GO:0005521 | lamin binding(GO:0005521) |
| 0.0 | 0.8 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
| 0.0 | 3.3 | GO:0005179 | hormone activity(GO:0005179) |
| 0.0 | 0.3 | GO:0042610 | CD8 receptor binding(GO:0042610) |
| 0.0 | 0.9 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
| 0.0 | 0.7 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
| 0.0 | 0.2 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
| 0.0 | 1.2 | GO:0070412 | R-SMAD binding(GO:0070412) |
| 0.0 | 0.3 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
| 0.0 | 0.1 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
| 0.0 | 0.3 | GO:0004849 | uridine kinase activity(GO:0004849) |
| 0.0 | 0.6 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
| 0.0 | 0.2 | GO:1903136 | cuprous ion binding(GO:1903136) |
| 0.0 | 3.0 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
| 0.0 | 0.1 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
| 0.0 | 0.3 | GO:0034235 | GPI anchor binding(GO:0034235) |
| 0.0 | 1.0 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
| 0.0 | 1.1 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
| 0.0 | 0.3 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
| 0.0 | 0.1 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
| 0.0 | 0.4 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
| 0.0 | 0.4 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
| 0.0 | 0.1 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
| 0.0 | 0.2 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
| 0.0 | 0.2 | GO:0034603 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
| 0.0 | 0.4 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
| 0.0 | 0.7 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
| 0.0 | 0.2 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
| 0.0 | 0.1 | GO:0070363 | mitochondrial light strand promoter sense binding(GO:0070363) |
| 0.0 | 0.1 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
| 0.0 | 0.4 | GO:0005344 | oxygen transporter activity(GO:0005344) |
| 0.0 | 0.6 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
| 0.0 | 0.3 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
| 0.0 | 0.4 | GO:0017147 | Wnt-protein binding(GO:0017147) |
| 0.0 | 0.2 | GO:0004875 | complement receptor activity(GO:0004875) |
| 0.0 | 0.4 | GO:0005537 | mannose binding(GO:0005537) |
| 0.0 | 0.6 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
| 0.0 | 0.2 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
| 0.0 | 0.2 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
| 0.0 | 1.5 | GO:0005507 | copper ion binding(GO:0005507) |
| 0.0 | 1.0 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
| 0.0 | 0.1 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
| 0.0 | 0.4 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
| 0.0 | 0.3 | GO:0050700 | CARD domain binding(GO:0050700) |
| 0.0 | 0.3 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
| 0.0 | 0.4 | GO:0005003 | ephrin receptor activity(GO:0005003) |
| 0.0 | 0.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
| 0.0 | 0.2 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
| 0.0 | 0.1 | GO:0004966 | galanin receptor activity(GO:0004966) |
| 0.0 | 0.1 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
| 0.0 | 0.1 | GO:0035403 | histone kinase activity (H3-T6 specific)(GO:0035403) |
| 0.0 | 0.1 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
| 0.0 | 0.3 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
| 0.0 | 0.1 | GO:0071566 | UFM1 activating enzyme activity(GO:0071566) |
| 0.0 | 0.1 | GO:0004397 | histidine ammonia-lyase activity(GO:0004397) |
| 0.0 | 0.1 | GO:0016749 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
| 0.0 | 0.2 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
| 0.0 | 0.2 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
| 0.0 | 0.2 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
| 0.0 | 0.0 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
| 0.0 | 0.4 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
| 0.0 | 0.2 | GO:0004396 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
| 0.0 | 0.4 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
| 0.0 | 0.3 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
| 0.0 | 2.3 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
| 0.0 | 0.3 | GO:0034485 | phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity(GO:0034485) |
| 0.0 | 0.1 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
| 0.0 | 0.5 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
| 0.0 | 0.1 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
| 0.0 | 0.2 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
| 0.0 | 0.3 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
| 0.0 | 0.1 | GO:0097003 | adipokinetic hormone receptor activity(GO:0097003) |
| 0.0 | 1.1 | GO:0097110 | scaffold protein binding(GO:0097110) |
| 0.0 | 0.6 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
| 0.0 | 0.3 | GO:0043274 | phospholipase binding(GO:0043274) |
| 0.0 | 0.3 | GO:0035254 | glutamate receptor binding(GO:0035254) |
| 0.0 | 0.2 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
| 0.0 | 0.4 | GO:0002039 | p53 binding(GO:0002039) |
| 0.0 | 0.6 | GO:0030506 | ankyrin binding(GO:0030506) |
| 0.0 | 0.2 | GO:0070064 | proline-rich region binding(GO:0070064) |
| 0.0 | 0.0 | GO:0016517 | interleukin-12 receptor activity(GO:0016517) |
| 0.0 | 0.5 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
| 0.0 | 1.4 | GO:0005262 | calcium channel activity(GO:0005262) |
| 0.0 | 0.2 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
| 0.0 | 0.4 | GO:0017025 | TBP-class protein binding(GO:0017025) |
| 0.0 | 0.0 | GO:0004568 | chitinase activity(GO:0004568) |
| 0.0 | 0.3 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
| 0.0 | 0.1 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
| 0.0 | 0.2 | GO:0005522 | profilin binding(GO:0005522) |
| 0.0 | 0.1 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
| 0.0 | 0.2 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
| 0.0 | 0.1 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
| 0.0 | 0.1 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
| 0.0 | 0.1 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
| 0.0 | 3.4 | GO:0030246 | carbohydrate binding(GO:0030246) |
| 0.0 | 0.2 | GO:0031005 | filamin binding(GO:0031005) |
| 0.0 | 0.1 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
Gene overrepresentation in C2:CP category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.3 | 0.3 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
| 0.3 | 1.3 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
| 0.3 | 1.0 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
| 0.1 | 10.5 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| 0.1 | 3.5 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
| 0.1 | 5.0 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
| 0.1 | 0.9 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
| 0.1 | 1.1 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
| 0.1 | 2.0 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
| 0.1 | 1.9 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
| 0.1 | 4.3 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
| 0.1 | 5.0 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
| 0.1 | 2.3 | ST G ALPHA S PATHWAY | G alpha s Pathway |
| 0.1 | 1.3 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
| 0.1 | 0.4 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
| 0.1 | 4.8 | PID AURORA B PATHWAY | Aurora B signaling |
| 0.1 | 6.1 | PID IL12 2PATHWAY | IL12-mediated signaling events |
| 0.1 | 15.9 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
| 0.1 | 1.2 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
| 0.0 | 1.2 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
| 0.0 | 0.8 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
| 0.0 | 1.1 | PID IL3 PATHWAY | IL3-mediated signaling events |
| 0.0 | 1.7 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
| 0.0 | 5.2 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
| 0.0 | 3.5 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
| 0.0 | 0.8 | PID AURORA A PATHWAY | Aurora A signaling |
| 0.0 | 2.8 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
| 0.0 | 3.3 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
| 0.0 | 0.8 | ST GA12 PATHWAY | G alpha 12 Pathway |
| 0.0 | 0.5 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
| 0.0 | 0.3 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
| 0.0 | 1.0 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
| 0.0 | 0.8 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
| 0.0 | 8.2 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.0 | 9.5 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.0 | 0.9 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
| 0.0 | 3.5 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
| 0.0 | 3.7 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
| 0.0 | 0.8 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
| 0.0 | 1.1 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
| 0.0 | 0.9 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
| 0.0 | 0.3 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
| 0.0 | 0.4 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
| 0.0 | 1.7 | PID ILK PATHWAY | Integrin-linked kinase signaling |
| 0.0 | 0.3 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
| 0.0 | 0.1 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
| 0.0 | 0.0 | ST GAQ PATHWAY | G alpha q Pathway |
| 0.0 | 0.3 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
| 0.0 | 0.3 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
| 0.0 | 1.5 | PID FANCONI PATHWAY | Fanconi anemia pathway |
| 0.0 | 0.4 | PID INSULIN PATHWAY | Insulin Pathway |
| 0.0 | 0.4 | PID ALK2 PATHWAY | ALK2 signaling events |
| 0.0 | 0.2 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
| 0.0 | 0.2 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
| 0.0 | 0.3 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
| 0.0 | 0.5 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
| 0.0 | 1.1 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
| 0.0 | 0.8 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 0.0 | 0.3 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
| 0.0 | 0.5 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
| 0.0 | 0.1 | PID IL23 PATHWAY | IL23-mediated signaling events |
| 0.0 | 0.7 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
Gene overrepresentation in C2:CP:REACTOME category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.4 | 8.5 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
| 0.3 | 7.8 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
| 0.3 | 11.4 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
| 0.3 | 10.6 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
| 0.3 | 3.9 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
| 0.3 | 5.1 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
| 0.2 | 2.7 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
| 0.2 | 14.2 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
| 0.2 | 7.9 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
| 0.2 | 4.6 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 0.2 | 7.4 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
| 0.1 | 7.2 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
| 0.1 | 3.5 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
| 0.1 | 2.9 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
| 0.1 | 0.8 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
| 0.1 | 1.5 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
| 0.1 | 2.7 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
| 0.1 | 0.7 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
| 0.1 | 3.3 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
| 0.1 | 0.9 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
| 0.1 | 2.2 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
| 0.1 | 0.9 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
| 0.1 | 1.4 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
| 0.1 | 2.1 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
| 0.1 | 2.6 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
| 0.1 | 2.2 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
| 0.1 | 1.0 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
| 0.1 | 1.1 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
| 0.1 | 2.5 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
| 0.1 | 2.5 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
| 0.1 | 0.6 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
| 0.1 | 1.1 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
| 0.1 | 2.2 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
| 0.1 | 4.5 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
| 0.1 | 5.3 | REACTOME CDK MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6 | Genes involved in CDK-mediated phosphorylation and removal of Cdc6 |
| 0.1 | 2.7 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
| 0.1 | 0.8 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
| 0.1 | 1.5 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
| 0.1 | 5.8 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
| 0.1 | 1.9 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
| 0.1 | 1.7 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
| 0.1 | 0.8 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
| 0.1 | 0.2 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
| 0.1 | 5.5 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
| 0.1 | 2.3 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
| 0.1 | 1.2 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
| 0.1 | 1.9 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
| 0.1 | 0.3 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
| 0.1 | 1.8 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
| 0.1 | 7.8 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
| 0.1 | 4.0 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
| 0.1 | 1.3 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
| 0.1 | 5.1 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
| 0.1 | 8.6 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
| 0.1 | 1.9 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
| 0.1 | 2.3 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
| 0.1 | 0.6 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
| 0.0 | 1.9 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
| 0.0 | 1.6 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
| 0.0 | 2.7 | REACTOME MEIOSIS | Genes involved in Meiosis |
| 0.0 | 2.4 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
| 0.0 | 0.5 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
| 0.0 | 0.9 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
| 0.0 | 1.0 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
| 0.0 | 1.6 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
| 0.0 | 5.2 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
| 0.0 | 0.6 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
| 0.0 | 1.8 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
| 0.0 | 0.6 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
| 0.0 | 1.7 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
| 0.0 | 0.3 | REACTOME CD28 CO STIMULATION | Genes involved in CD28 co-stimulation |
| 0.0 | 0.1 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
| 0.0 | 0.9 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
| 0.0 | 1.8 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
| 0.0 | 0.6 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
| 0.0 | 0.2 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
| 0.0 | 0.7 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
| 0.0 | 1.7 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
| 0.0 | 0.5 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
| 0.0 | 0.2 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
| 0.0 | 3.9 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
| 0.0 | 0.5 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
| 0.0 | 1.4 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
| 0.0 | 0.2 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
| 0.0 | 0.4 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
| 0.0 | 1.0 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
| 0.0 | 1.8 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
| 0.0 | 0.9 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
| 0.0 | 0.6 | REACTOME RNA POL II PRE TRANSCRIPTION EVENTS | Genes involved in RNA Polymerase II Pre-transcription Events |
| 0.0 | 0.5 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
| 0.0 | 0.2 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
| 0.0 | 2.9 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
| 0.0 | 0.2 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
| 0.0 | 0.6 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
| 0.0 | 0.3 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
| 0.0 | 0.4 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
| 0.0 | 1.1 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
| 0.0 | 0.3 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
| 0.0 | 0.1 | REACTOME CDT1 ASSOCIATION WITH THE CDC6 ORC ORIGIN COMPLEX | Genes involved in CDT1 association with the CDC6:ORC:origin complex |
| 0.0 | 0.2 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
| 0.0 | 0.3 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
| 0.0 | 0.4 | REACTOME AMYLOIDS | Genes involved in Amyloids |
| 0.0 | 0.7 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
| 0.0 | 0.2 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
| 0.0 | 0.2 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
| 0.0 | 0.8 | REACTOME RNA POL III TRANSCRIPTION | Genes involved in RNA Polymerase III Transcription |
| 0.0 | 0.2 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
| 0.0 | 0.8 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
| 0.0 | 0.6 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |